Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 678.0;Distal tubular cells: 994.7;Proximal tubular cells: 716.2;Syncytiotrophoblasts: 483.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		51000000	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	30.1	60.0	34.7	30.3	45.8	22.4	33.9	52.6	65.0	27.0	52.1	20.5	39.3	55.6	25.2	30.5	44.4	30.0	27.9	196.2	31.4	36.1	94.0	64.8	25.2	40.2	42.3	31.8	28.6	49.0	73.2	35.9	25.7	41.5	28.3	54.9	37.6	42.6	42.8	182.2	34.0	50.4	36.6	22.6	32.1	46.7	24.0	19.9	45.6	35.1	99.7	41.1	31.5	26.4	58.7	110.9	17.9	64.5	44.2	63.6	124.8	43.2	44.1	58.7	55.1	71.5	79.5	65.1	50.1	71.1	77.2	67.7	66.0	34.2	102.6	30.7	60.6	41.4	80.7	101.1	76.9	72.1	45.6	56.8	67.8	56.9	81.7	46.9	143.4	64.4	73.2	54.0	55.6	58.0	62.1	79.6	55.7	54.7	60.7	66.0	45.0	73.7	70.6	55.0	42.4	46.6	73.0	68.3	138.6	104.7	105.9	59.8	55.8	36.7	45.9	61.5	57.6	59.1	83.8	46.3	42.5	36.8	22.3	43.6	69.7	59.6	66.1	42.4	86.3	45.2	11.8	64.5	17.9	43.5	58.2	55.8	58.7	52.4	47.5	110.9	44.0	63.6	52.8	6.7	44.2	52.2	54.0	58.9	124.8	34.7	45.8	52.6	65.0	31.4	36.1	42.3	31.8	41.5	19.9	157.8	126.7	0.0	0.0	0.0	0.0	0.0	0.0	175.3	184.2	162.3	0.0	678.0	994.7	285.1	0.0	0.0	0.0	0.0	236.7	359.7	0.0	0.0	82.5	0.0	363.9	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	313.8	0.0	0.0	195.3	0.0	0.0	716.2	0.0	0.0	0.0	0.0	0.0	0.0	483.5	0.0	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	66.5	81.0	64.4	99.3	58.1	62.1	113.8	67.7	63.2	117.1	66.8	131.5	74.3	118.4	73.4	83.4	49.0	89.2	135.6	82.1	106.1	55.5	93.9	129.9	75.6	80.6	72.0	145.2	92.0	76.1	82.9	91.5	118.2	89.2	96.2	88.4	116.9	136.5	98.2	61.7	107.5	85.4	108.4	88.2	156.0	103.7	72.1	150.9	127.5	118.6	73.7	65.5	103.5	148.2	115.1	70.7	139.1	109.8	65.2	46.1	51.4	67.3	73.1	65.9	81.9	122.5	69.4	97.2	70.6	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3	125.0	160.8	0.0	0.0	0.0	0.0	0.0	0.0	188.7	149.0	263.5	0.0	693.2	1049.5	441.8	0.0	0.0	0.0	0.0	323.3	482.8	0.0	0.0	133.7	0.0	535.7	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	490.5	0.0	0.0	298.7	0.0	0.0	698.1	0.0	0.0	0.0	0.0	0.0	0.0	952.2	0.0	0.0	0.0
ATP5F1C	"ATP5C, ATP5C1, ATP5CL1"	ENSG00000165629	"ATP synthase F1 subunit gamma"	P36542	10	7788129-7807815	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 423.9;Distal tubular cells: 754.4;Ductal cells: 393.1;Proximal tubular cells: 726.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060949	Approved					NA	NA		2600000			"HPA060949: AB_2684395"	"unprognostic (1.81e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.12e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.08e-2)"	35.3	75.5	30.9	24.4	33.5	23.1	31.4	27.8	38.7	26.1	48.5	20.3	25.7	45.3	27.6	30.4	48.2	22.2	30.5	138.0	29.5	28.5	98.2	70.9	21.6	21.4	30.3	28.1	22.9	46.9	43.3	23.3	38.8	43.6	26.7	52.1	26.9	46.2	29.2	98.1	24.9	64.5	33.6	23.2	30.4	38.1	18.0	18.7	45.8	35.7	97.9	34.1	39.7	23.1	42.0	75.7	57.5	75.5	41.0	51.3	59.2	43.1	39.5	39.7	33.0	36.0	47.8	37.1	31.1	28.7	58.4	57.4	78.0	42.7	47.8	23.9	39.6	14.3	48.7	46.7	51.6	51.4	32.4	57.5	51.2	27.1	68.3	27.8	27.7	37.3	37.9	36.2	35.2	19.2	50.7	68.3	48.1	40.3	33.7	57.2	63.6	65.1	32.0	25.5	91.7	32.0	42.4	29.8	65.4	98.9	42.8	21.2	25.9	28.5	61.3	55.1	46.4	65.5	45.6	32.7	24.7	31.1	53.4	33.1	22.5	27.9	38.8	35.6	41.8	19.8	57.5	55.4	46.0	33.6	71.9	38.5	42.0	38.2	36.2	75.7	32.1	31.8	34.6	17.7	41.0	75.5	50.8	51.3	59.2	30.9	33.5	27.8	38.7	29.5	28.5	30.3	28.1	43.6	18.7	110.2	82.5	0.0	0.0	0.0	0.0	0.0	0.0	119.1	111.5	204.1	0.0	423.9	754.4	393.1	0.0	0.0	0.0	0.0	332.8	348.6	0.0	0.0	89.5	0.0	367.4	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	245.3	0.0	0.0	290.9	0.0	0.0	726.6	0.0	0.0	0.0	0.0	0.0	0.0	311.0	0.0	0.0	0.0
ATP5F1D	ATP5D	ENSG00000099624	"ATP synthase F1 subunit delta"	P30049	19	1241746-1244826	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 337.3"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 1442.3;Exocrine glandular cells: 487.7;Proximal tubular cells: 1282.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002865	Approved					NA	NA		4200000			"HPA002865: AB_1078244"	"unprognostic (4.80e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.77e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	30.4	25.7	27.4	13.7	30.1	19.5	19.8	22.6	51.7	14.4	36.7	16.7	16.0	42.7	14.3	14.9	23.9	15.3	18.1	59.3	25.9	20.6	33.3	51.8	12.2	33.4	25.6	24.1	15.2	46.5	15.5	18.4	12.4	28.5	17.6	14.1	17.9	48.1	23.1	337.3	24.3	33.2	21.1	14.5	19.2	33.4	10.2	9.8	21.5	23.0	60.6	22.9	17.6	14.5	67.7	78.2	33.9	64.6	52.8	64.3	50.8	24.4	13.4	4.2	15.7	4.9	7.2	15.7	16.8	7.1	10.0	7.3	14.0	6.5	24.9	10.9	5.8	2.5	21.1	4.7	17.5	1.3	17.2	45.6	15.0	16.5	18.2	12.2	26.3	22.4	14.3	4.8	4.0	5.6	5.6	10.6	16.8	21.8	19.9	4.6	37.2	28.5	19.0	18.2	15.7	66.3	27.2	11.1	51.7	16.6	16.2	16.8	19.3	11.2	17.9	27.7	1.7	13.3	12.5	15.3	9.1	12.5	21.9	13.9	51.0	25.7	9.2	16.9	12.5	13.7	33.9	64.6	27.1	50.7	61.3	61.1	64.8	64.3	55.7	72.1	67.7	59.9	54.9	22.5	52.8	49.0	78.2	62.0	50.8	27.4	30.1	22.6	51.7	25.9	20.6	25.6	24.1	28.5	9.8	14.9	23.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.0	361.2	0.0	333.1	1442.3	304.6	0.0	0.0	0.0	0.0	487.7	366.7	0.0	0.0	4.7	0.0	365.7	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	232.6	0.0	0.0	350.7	0.0	0.0	1282.8	0.0	0.0	0.0	0.0	0.0	0.0	285.4	0.0	0.0	0.0
ATP5F1E	ATP5E	ENSG00000124172	"ATP synthase F1 subunit epsilon"	P56381	20	59025467-59032382	"Disease related genes, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 2893.1;Hofbauer cells: 2375.8;monocytes: 2569.9;Proximal tubular cells: 2056.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.73e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (3.98e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-2)"	47.2	58.1	41.9	58.8	44.2	65.7	55.2	26.9	43.7	19.4	40.2	15.6	29.5	50.5	22.1	29.4	29.8	16.6	29.6	93.2	33.0	33.1	43.6	42.2	41.0	56.9	42.8	26.5	17.8	44.1	13.0	44.0	22.3	40.0	22.4	21.8	16.6	32.9	25.6	133.3	15.7	48.5	40.4	42.8	41.8	42.4	23.5	21.4	26.7	29.7	60.3	24.9	22.3	28.6	48.8	85.9	103.7	63.8	32.6	54.2	88.6	28.6	9.4	19.6	17.9	18.6	17.5	13.1	30.7	11.5	20.1	13.0	29.4	28.4	15.6	37.5	15.2	32.2	27.8	13.4	23.3	13.4	12.8	14.4	52.4	21.4	25.3	17.0	36.8	47.3	18.5	20.6	12.1	15.2	20.1	14.9	21.2	19.5	22.7	11.4	26.6	46.9	57.4	6.6	42.3	38.9	23.1	27.8	30.0	20.4	15.7	19.7	29.7	51.5	54.7	59.6	17.6	36.4	60.6	51.9	42.3	44.7	27.9	41.3	36.4	46.2	46.4	41.0	23.0	23.2	66.1	59.6	102.8	36.0	63.8	34.2	48.8	44.1	40.4	50.6	41.4	35.6	39.7	103.7	32.6	62.8	85.9	54.2	88.6	41.9	44.2	26.9	43.7	33.0	33.1	42.8	26.5	40.0	21.4	479.4	532.6	0.0	0.0	0.0	0.0	0.0	0.0	721.4	532.3	1064.3	0.0	617.9	2893.1	877.4	0.0	0.0	0.0	0.0	1043.7	805.3	0.0	0.0	324.4	0.0	2375.8	0.0	0.0	0.0	0.0	0.0	0.0	681.8	0.0	2569.9	0.0	0.0	1179.5	0.0	0.0	2056.5	0.0	0.0	0.0	0.0	0.0	0.0	493.8	0.0	0.0	0.0
ATP5MC1	"ATP5G, ATP5G1"	ENSG00000159199	"ATP synthase membrane subunit c locus 1"	P05496	17	48892765-48895871	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"heart muscle: 117.9"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 349.4;Distal tubular cells: 1228.5;Proximal tubular cells: 646.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 210.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (3.43e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (6.60e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.73e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (9.42e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (8.24e-6)"	"unprognostic (2.07e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.33e-1)"	11.7	19.2	29.2	16.4	34.2	12.4	17.6	15.8	35.4	13.6	46.8	9.5	11.1	28.3	13.5	24.7	22.2	16.0	13.0	117.9	26.2	21.6	47.9	33.0	11.2	18.3	23.0	28.5	11.0	27.7	15.5	15.0	10.4	27.8	12.3	47.0	10.8	29.5	16.4	103.8	14.3	43.2	19.7	16.1	11.4	21.3	6.1	13.2	8.7	17.3	106.0	21.5	10.4	12.9	67.5	86.3	13.8	52.9	39.3	49.6	49.7	49.3	66.7	21.2	30.9	23.4	28.6	31.3	27.2	22.9	36.4	36.0	44.3	35.6	54.4	65.8	23.5	38.7	45.1	38.0	47.6	54.2	44.7	50.9	52.7	44.1	88.4	16.4	62.8	26.5	23.1	32.5	38.6	42.8	19.6	40.9	44.5	31.4	36.9	41.9	50.8	59.4	29.4	13.2	210.8	65.9	37.9	55.3	87.5	69.2	28.1	31.5	22.9	20.4	43.9	23.1	33.7	64.5	42.9	22.6	23.0	31.6	34.7	34.6	33.7	37.9	72.0	33.1	49.8	27.2	9.1	52.9	13.8	32.2	44.5	38.8	67.5	37.0	34.6	70.1	54.5	49.6	43.1	2.9	39.3	25.7	86.3	31.2	49.7	29.2	34.2	15.8	35.4	26.2	21.6	23.0	28.5	27.8	13.2	44.7	79.4	0.0	0.0	0.0	0.0	0.0	0.0	97.7	91.0	260.0	0.0	349.4	1228.5	161.3	0.0	0.0	0.0	0.0	257.7	210.1	0.0	0.0	67.4	0.0	239.2	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	126.2	0.0	0.0	170.7	0.0	0.0	646.5	0.0	0.0	0.0	0.0	0.0	0.0	185.9	0.0	0.0	0.0
ATP5MC2	ATP5G2	ENSG00000135390	"ATP synthase membrane subunit c locus 2"	Q06055	12	53632726-53677408	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1493.8;Hofbauer cells: 948.2;Proximal tubular cells: 1347.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051469	Approved					NA	NA					"HPA051469: AB_2681496"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (3.78e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.09e-2)"	39.1	60.1	52.8	34.8	48.0	49.7	64.3	47.4	72.1	46.4	57.0	49.5	38.2	50.3	57.0	63.3	52.3	71.2	48.2	107.6	45.9	43.7	60.3	60.1	46.8	105.6	49.3	57.9	67.3	99.2	47.9	50.8	34.0	42.2	46.4	73.3	49.7	69.1	43.1	165.8	50.3	45.4	53.3	51.3	51.6	57.4	38.1	32.9	82.1	46.2	92.9	67.0	47.4	41.7	112.1	133.4	30.2	96.4	71.7	99.0	126.2	27.5	59.0	62.3	56.3	43.0	105.1	29.3	24.3	54.7	72.6	49.8	20.1	65.2	33.4	59.7	47.5	23.6	26.6	79.6	56.3	64.6	55.9	95.3	91.2	47.6	41.4	93.6	69.3	45.5	116.7	83.9	70.3	117.2	117.6	93.2	41.0	64.6	98.9	73.6	72.2	70.7	169.1	53.1	58.4	65.9	71.5	59.1	83.0	88.5	34.7	32.5	59.6	32.8	38.2	81.8	56.9	123.9	126.6	44.5	35.6	49.1	27.3	37.6	51.8	43.3	24.3	53.0	73.2	54.4	30.2	96.4	27.1	68.9	89.6	75.8	112.1	89.2	73.6	133.4	99.5	99.0	81.4	22.0	71.7	79.5	103.0	92.7	126.2	52.8	48.0	47.4	72.1	45.9	43.7	49.3	57.9	42.2	32.9	169.7	211.4	0.0	0.0	0.0	0.0	0.0	0.0	396.2	325.3	500.7	0.0	597.2	1493.8	365.1	0.0	0.0	0.0	0.0	588.0	662.7	0.0	0.0	206.9	0.0	948.2	0.0	0.0	0.0	0.0	0.0	0.0	161.9	0.0	664.6	0.0	0.0	433.3	0.0	0.0	1347.7	0.0	0.0	0.0	0.0	0.0	0.0	424.6	0.0	0.0	0.0
ATP5MC3	ATP5G3	ENSG00000154518	"ATP synthase membrane subunit c locus 3"	P48201	2	175176258-175184607	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 189.6"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 786.5;Distal tubular cells: 2259.7;Extravillous trophoblasts: 831.6;Hofbauer cells: 886.9;Proximal tubular cells: 1680.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (4.45e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.31e-6)"	"unprognostic (2.86e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.31e-2)"	26.1	26.7	26.6	26.3	28.7	19.8	34.3	26.9	50.9	15.7	51.1	11.4	23.6	61.7	17.4	22.2	38.9	15.5	28.7	189.6	25.8	27.4	63.9	60.8	21.2	34.8	31.1	31.5	13.6	28.4	36.7	19.0	16.8	27.6	17.1	53.3	16.6	34.2	25.0	115.7	20.0	47.3	24.6	18.5	17.6	31.9	12.3	15.8	21.8	19.1	95.9	27.7	19.3	20.2	38.5	78.8	22.6	59.9	34.5	37.2	66.1	33.7	30.2	45.6	50.3	39.1	34.8	51.3	31.3	33.0	44.3	38.7	90.2	28.3	84.3	37.0	34.9	49.0	44.7	57.3	54.1	46.9	35.4	52.8	67.7	44.1	114.0	30.1	87.5	41.0	37.4	41.8	50.0	31.9	34.2	44.4	40.8	73.0	40.5	48.4	46.3	67.5	73.9	59.9	81.6	94.6	53.0	42.1	82.7	86.3	76.8	40.9	26.0	25.2	68.6	68.2	68.1	41.3	71.5	29.6	7.4	35.4	0.2	43.0	32.0	40.4	72.9	42.5	52.8	33.0	17.6	53.4	22.6	33.3	59.9	33.6	38.5	35.3	36.1	78.8	30.4	33.5	35.9	6.2	34.5	53.7	58.3	37.2	66.1	26.6	28.7	26.9	50.9	25.8	27.4	31.1	31.5	27.6	15.8	163.8	131.1	0.0	0.0	0.0	0.0	0.0	0.0	238.3	230.9	294.8	0.0	786.5	2259.7	429.4	0.0	0.0	0.0	0.0	326.9	831.6	0.0	0.0	81.4	0.0	886.9	0.0	0.0	0.0	0.0	0.0	0.0	111.5	0.0	358.9	0.0	0.0	350.5	0.0	0.0	1680.5	0.0	0.0	0.0	0.0	0.0	0.0	577.8	0.0	0.0	0.0
ATP5MD	"bA792D24.4, DAPIT, MGC14697, USMG5"	ENSG00000173915	"ATP synthase membrane subunit DAPIT"	Q96IX5	10	103389041-103396466	"Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044798			Supported	Mitochondria		NA	NA			Mitochondria		"HPA044798: AB_2679091"	"unprognostic (4.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.03e-2)"	48.0	46.2	91.7	26.2	67.0	26.6	56.1	33.5	71.7	38.4	77.9	21.2	29.2	43.8	22.1	72.3	56.3	28.8	31.0	131.5	67.8	57.4	79.3	92.5	24.6	27.7	65.2	44.4	19.7	58.1	21.1	38.2	25.9	46.0	30.0	75.8	23.4	52.7	43.3	146.9	22.4	57.3	39.1	41.4	26.1	40.9	20.2	30.7	22.9	31.3	125.5	39.8	41.2	28.9	71.3	109.1	101.2	85.2	50.7	76.6	66.4	60.6	64.4	61.0	72.7	68.2	85.7	39.9	58.4	73.7	59.7	66.8	103.7	67.7	34.9	33.9	66.0	47.2	62.2	57.1	59.5	82.4	45.8	102.5	36.2	83.0	115.9	66.3	73.8	56.2	69.1	93.4	53.6	84.8	102.3	76.9	56.6	47.4	58.3	99.7	94.1	59.9	127.2	45.3	93.2	109.2	38.9	37.2	54.3	141.9	98.9	23.1	53.5	30.8	47.3	84.0	89.1	42.0	68.6	43.5	29.6	45.3	44.8	76.4	61.5	100.4	58.2	62.5	75.8	22.3	101.2	65.9	88.7	55.9	85.2	63.3	71.3	76.6	65.7	73.3	51.5	65.9	65.6	55.8	50.7	80.6	109.1	71.7	66.4	91.7	67.0	33.5	71.7	67.8	57.4	65.2	44.4	46.0	30.7	196.5	169.5	0.0	0.0	0.0	0.0	0.0	0.0	222.1	167.2	368.2	0.0	256.1	1135.7	625.1	0.0	0.0	0.0	0.0	623.7	361.7	0.0	0.0	109.3	0.0	478.9	0.0	0.0	0.0	0.0	0.0	0.0	129.1	0.0	754.8	0.0	0.0	789.0	0.0	0.0	951.7	0.0	0.0	0.0	0.0	0.0	0.0	255.7	0.0	0.0	0.0
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674338	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		NA	NA		220000	Mitochondria		"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	41.2	48.1	69.3	30.8	69.0	34.4	34.2	27.7	67.6	29.3	66.6	28.2	44.4	60.0	20.5	34.1	40.1	23.1	31.6	95.8	62.0	49.2	47.5	68.9	25.8	25.2	68.6	48.7	26.2	57.9	24.5	26.6	19.6	62.2	23.9	43.9	17.8	40.7	37.2	221.8	22.3	55.6	45.8	67.2	23.3	40.7	14.1	47.7	10.9	22.1	98.7	28.1	18.9	31.1	166.1	148.1	142.2	135.7	107.4	127.6	158.4	49.9	47.3	68.2	55.5	57.4	53.4	38.0	48.7	39.0	37.0	32.9	45.4	49.5	25.9	46.9	51.5	60.1	32.0	54.9	76.8	20.3	22.9	101.4	76.2	87.7	113.3	59.7	97.0	33.6	66.2	45.1	42.4	43.0	57.8	45.2	51.7	63.0	28.4	41.9	72.0	83.6	127.1	80.1	88.1	123.8	51.0	49.8	56.4	70.7	87.2	66.2	52.0	35.4	47.7	54.0	44.7	54.5	66.9	52.4	33.3	31.6	29.3	67.9	66.4	109.5	81.9	48.9	66.9	36.4	103.7	135.7	142.2	98.5	112.1	101.0	166.1	121.1	109.2	135.4	123.2	110.3	110.3	122.3	107.4	97.7	148.1	127.6	158.4	69.3	69.0	27.7	67.6	62.0	49.2	68.6	48.7	62.2	47.7	142.9	207.3	0.0	0.0	0.0	0.0	0.0	0.0	337.3	224.1	840.9	0.0	343.2	1465.6	413.4	0.0	0.0	0.0	0.0	598.1	265.5	0.0	0.0	112.8	0.0	580.0	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	485.1	0.0	0.0	478.0	0.0	0.0	1359.9	0.0	0.0	0.0	0.0	0.0	0.0	229.9	0.0	0.0	0.0
ATP5MF	"ATP5J2, ATP5JL"	ENSG00000241468	"ATP synthase membrane subunit f"	P56134	7	99448475-99466331	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067267, HPA070412"	Approved		Supported	"Nuclear membrane,Mitochondria"		NA	NA		1400000	Mitochondria	"Nuclear membrane"	"HPA067267: AB_2685815, HPA070412: AB_2686266"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.55e-3)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.31e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.78e-2)"	42.4	49.0	68.0	36.6	52.0	46.4	42.8	37.3	58.8	30.7	62.7	19.0	39.9	62.9	21.2	41.2	57.4	24.8	36.6	94.5	53.9	49.8	59.6	93.5	30.0	35.5	54.6	43.6	20.7	63.6	16.3	36.7	33.4	36.3	35.0	47.3	30.9	57.1	45.2	178.8	27.8	61.5	24.6	33.0	35.6	43.4	58.3	25.5	52.9	37.9	98.0	37.6	27.8	30.2	68.3	129.7	117.2	104.1	58.3	84.0	140.0	86.7	76.6	64.6	104.3	50.9	51.7	40.9	57.6	44.9	61.9	67.1	81.3	80.2	81.4	60.8	35.7	105.4	53.5	71.4	66.0	66.2	58.6	91.7	55.1	122.5	104.8	38.4	93.9	63.1	58.9	63.7	53.8	57.0	54.2	58.9	70.6	111.7	89.7	64.8	203.9	140.4	163.0	91.9	174.2	90.2	62.9	53.9	139.1	130.5	96.5	62.1	68.5	75.4	186.6	54.5	100.7	47.0	121.9	49.9	54.5	87.2	90.0	84.0	51.4	118.1	169.8	63.1	91.9	83.7	90.0	104.0	117.2	54.2	104.1	51.7	68.3	63.5	61.0	129.7	56.9	55.8	59.5	49.7	58.3	79.2	102.7	84.0	140.0	68.0	52.0	37.3	58.8	53.9	49.8	54.6	43.6	36.3	25.5	20.8	44.7	0.0	0.0	0.0	0.0	0.0	0.0	93.7	67.1	366.4	0.0	700.3	1212.0	418.8	0.0	0.0	0.0	0.0	501.7	525.7	0.0	0.0	59.3	0.0	681.7	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	591.5	0.0	0.0	502.5	0.0	0.0	993.9	0.0	0.0	0.0	0.0	0.0	0.0	364.9	0.0	0.0	0.0
ATP5MG	"ATP5JG, ATP5L"	ENSG00000167283	"ATP synthase membrane subunit g"	O75964	11	118401154-118431496	"Predicted intracellular proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 1200.8;Distal tubular cells: 2463.7;Hofbauer cells: 1173.9;monocytes: 1183.1;Proximal tubular cells: 1669.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044629	Approved		Supported	Mitochondria		NA	NA		590000	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (1.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.41e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (6.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.05e-2)"	32.3	42.4	45.3	31.8	46.7	36.0	39.6	38.1	40.4	25.6	39.0	21.1	30.3	33.8	33.9	40.4	27.9	26.5	30.1	85.8	37.5	38.4	55.6	42.6	29.1	41.9	39.2	23.6	31.3	70.1	25.8	31.1	23.6	28.3	26.3	41.5	39.0	71.9	29.5	68.4	20.9	39.5	47.3	27.8	30.7	29.5	17.9	15.7	53.2	33.7	60.2	43.7	30.0	23.6	42.7	54.6	30.8	48.0	32.5	53.5	98.1	21.4	11.1	29.3	28.4	25.4	28.4	23.5	22.0	25.0	20.2	21.5	28.1	34.8	42.6	46.0	23.9	31.7	27.4	29.5	30.8	22.5	34.0	19.4	67.3	10.5	16.9	26.0	38.2	32.3	30.2	29.2	24.9	23.7	23.8	27.1	32.3	30.7	35.7	28.1	38.4	53.4	47.7	18.6	60.6	31.0	36.7	24.6	46.8	52.5	18.5	23.3	17.6	33.2	53.8	16.2	33.9	39.1	35.7	26.6	16.7	18.7	14.3	25.1	16.3	22.3	43.3	12.4	44.6	20.8	28.8	48.0	30.8	27.1	33.3	39.3	42.7	42.9	35.5	49.9	34.6	53.5	40.2	24.0	32.5	31.5	54.6	45.8	98.1	45.3	46.7	38.1	40.4	37.5	38.4	39.2	23.6	28.3	15.7	336.5	314.3	0.0	0.0	0.0	0.0	0.0	0.0	345.3	306.0	579.3	0.0	1200.8	2463.7	680.9	0.0	0.0	0.0	0.0	858.6	734.2	0.0	0.0	238.3	0.0	1173.9	0.0	0.0	0.0	0.0	0.0	0.0	317.5	0.0	1183.1	0.0	0.0	798.2	0.0	0.0	1669.9	0.0	0.0	0.0	0.0	0.0	0.0	837.4	0.0	0.0	0.0
ATP5MPL	"6.8PL, C14orf2, MLQ, MP68"	ENSG00000156411	"ATP synthase membrane subunit 6.8PL"	P56378	14	103912288-103928269	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058978, HPA060520"	Approved		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA058978: AB_2683867, HPA060520: AB_2684302"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.14e-2)"	23.1	34.5	69.4	19.3	64.3	40.2	34.9	31.0	91.7	21.0	43.0	16.0	26.8	44.1	16.5	39.1	27.3	21.3	20.5	87.5	57.5	44.7	43.0	45.2	15.7	28.6	54.0	41.4	22.1	38.2	17.2	29.2	20.5	30.4	22.1	45.6	20.1	28.9	30.3	117.3	17.3	33.6	24.6	28.5	19.5	25.8	17.5	24.4	18.9	23.6	58.9	30.9	18.4	17.2	51.8	63.1	91.6	91.0	32.8	54.6	98.1	37.9	43.8	38.0	36.1	45.5	47.3	37.5	29.7	33.7	37.3	32.7	37.8	27.0	39.8	31.4	30.4	30.1	32.4	48.9	35.8	50.6	32.9	49.3	44.4	37.1	58.1	30.1	53.6	30.9	49.6	48.8	25.3	27.1	42.9	41.9	53.7	26.9	42.7	41.0	112.7	51.8	76.6	29.7	88.5	83.8	33.3	33.2	36.1	56.8	54.0	32.9	39.3	24.9	46.7	56.0	43.9	57.8	63.8	22.5	14.7	23.0	39.6	24.3	32.8	55.7	55.7	34.4	30.6	24.7	54.8	91.0	55.0	37.5	68.0	41.7	51.8	47.8	42.3	63.1	43.6	54.6	48.4	91.6	32.8	65.0	61.2	46.5	98.1	69.4	64.3	31.0	91.7	57.5	44.7	54.0	41.4	30.4	24.4	205.4	192.2	0.0	0.0	0.0	0.0	0.0	0.0	269.0	169.5	392.6	0.0	537.4	1357.9	448.4	0.0	0.0	0.0	0.0	495.8	570.0	0.0	0.0	86.0	0.0	793.2	0.0	0.0	0.0	0.0	0.0	0.0	158.5	0.0	585.3	0.0	0.0	512.8	0.0	0.0	1064.7	0.0	0.0	0.0	0.0	0.0	0.0	593.8	0.0	0.0	0.0
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		640000	Mitochondria		"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.26e-9)"	"prognostic favorable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	11.6	16.0	16.8	11.4	22.6	8.0	10.4	30.7	28.8	10.7	30.0	10.4	11.3	16.1	14.4	10.7	21.1	13.7	9.7	57.1	16.4	15.4	30.5	26.2	10.2	14.2	16.1	15.5	12.6	15.3	18.0	13.3	16.3	22.8	13.4	17.8	9.8	20.4	12.4	83.6	9.7	25.4	13.7	13.9	13.7	13.1	11.4	10.1	18.7	18.6	34.0	15.4	15.5	11.5	8.3	10.8	4.3	10.0	5.9	11.9	22.9	15.3	3.5	13.0	10.1	8.4	7.6	8.4	17.0	18.8	17.7	14.7	6.2	7.8	20.9	15.8	11.1	3.8	16.0	18.9	21.0	15.8	16.6	7.4	20.9	4.9	4.1	6.1	26.3	21.1	6.6	9.0	19.4	18.2	4.1	14.1	2.9	18.4	9.2	10.1	7.1	44.9	6.1	9.9	4.0	24.0	11.6	40.6	8.2	14.0	5.2	9.5	3.0	13.2	18.9	13.9	3.1	15.2	9.5	13.6	8.3	14.7	16.2	16.8	12.7	12.1	49.8	20.1	20.0	15.5	1.9	10.0	4.3	9.7	6.4	8.6	7.5	10.8	9.2	10.8	8.3	11.9	7.3	2.9	5.9	5.0	5.9	9.0	22.9	16.8	22.6	30.7	28.8	16.4	15.4	16.1	15.5	22.8	10.1	62.5	73.9	0.0	0.0	0.0	0.0	0.0	0.0	136.5	105.8	118.7	0.0	297.5	391.3	205.2	0.0	0.0	0.0	0.0	172.3	335.0	0.0	0.0	82.5	0.0	328.7	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	172.3	0.0	0.0	151.6	0.0	0.0	348.8	0.0	0.0	0.0	0.0	0.0	0.0	290.7	0.0	0.0	0.0
ATP5PD	"ATP5H, ATP5JD, ATPQ"	ENSG00000167863	"ATP synthase peripheral stalk subunit d"	O75947	17	75038863-75046985	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 968.2;Proximal tubular cells: 714.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042777, HPA048459"	Enhanced		Supported	Mitochondria		NA	NA		1600000	Mitochondria		"HPA042777: AB_2678160, HPA048459: AB_2680402"	"unprognostic (1.37e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.29e-2)"	38.8	38.5	54.3	28.6	48.6	25.6	37.8	34.5	50.4	30.0	52.9	19.6	33.2	46.6	25.8	47.4	58.9	25.7	31.0	143.6	47.7	44.8	78.8	86.2	24.8	29.2	45.7	39.2	28.5	43.3	38.5	29.8	35.4	40.3	33.1	53.1	35.4	56.8	36.3	184.2	35.5	59.9	39.1	32.8	32.7	40.4	15.7	21.3	30.3	48.7	88.5	33.7	45.8	29.0	72.5	100.7	90.9	103.8	54.9	100.0	86.2	63.5	55.8	42.8	55.7	69.8	85.4	57.5	54.7	72.2	61.4	58.6	43.6	50.0	43.1	36.4	68.4	57.9	58.0	51.5	71.7	82.4	20.9	43.7	44.0	46.5	85.9	68.7	56.0	28.9	72.5	57.1	49.9	71.4	49.1	81.7	33.7	45.8	58.8	75.4	61.7	55.4	63.0	32.6	146.1	79.4	39.4	124.0	79.9	126.9	62.2	43.1	47.4	64.6	103.0	87.1	66.8	102.1	57.2	42.1	76.5	53.5	66.4	63.8	47.3	37.3	44.1	68.5	56.3	49.2	67.2	90.5	90.9	58.3	103.8	67.4	72.5	100.0	71.6	100.7	57.6	90.9	83.5	50.7	54.9	83.1	89.8	94.6	86.2	54.3	48.6	34.5	50.4	47.7	44.8	45.7	39.2	40.3	21.3	160.8	115.9	0.0	0.0	0.0	0.0	0.0	0.0	186.0	188.8	246.0	0.0	327.6	968.2	259.9	0.0	0.0	0.0	0.0	330.1	269.2	0.0	0.0	81.4	0.0	401.2	0.0	0.0	0.0	0.0	0.0	0.0	121.7	0.0	364.3	0.0	0.0	268.3	0.0	0.0	714.6	0.0	0.0	0.0	0.0	0.0	0.0	281.2	0.0	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 2012.7;Proximal tubular cells: 1143.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031069	Supported		Supported	Mitochondria		NA	NA		720000	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	39.8	46.8	49.0	20.3	43.6	23.0	32.6	30.8	46.6	25.9	48.6	26.1	22.4	43.0	24.0	57.4	45.2	21.6	19.2	148.9	41.1	37.1	72.8	111.0	18.7	22.2	47.0	27.0	23.9	37.4	31.2	37.5	33.9	45.7	32.6	47.9	33.9	47.1	37.5	164.7	18.7	57.9	46.9	32.8	25.0	37.6	21.0	25.8	31.4	32.1	69.9	29.9	42.0	23.1	87.8	102.4	80.9	91.5	69.1	95.2	112.2	41.8	30.1	38.4	43.1	41.4	38.1	47.7	37.0	43.1	36.2	35.4	69.1	33.0	51.5	24.5	36.5	57.9	22.9	51.4	44.4	39.9	45.0	54.6	107.4	61.2	68.6	46.8	78.4	35.2	37.2	54.8	34.6	31.1	49.3	42.0	49.8	67.0	63.4	52.8	46.7	54.3	79.4	69.0	94.8	54.7	42.5	74.7	97.3	77.2	57.2	43.9	48.8	62.2	62.9	57.0	56.8	45.5	70.7	31.7	27.7	33.2	25.8	31.8	63.3	103.5	65.2	42.5	82.1	34.7	69.2	88.8	80.9	60.3	91.5	64.0	87.8	80.2	74.6	102.4	71.6	79.6	78.0	56.9	69.1	89.7	96.4	95.2	112.2	49.0	43.6	30.8	46.6	41.1	37.1	47.0	27.0	45.7	25.8	157.8	157.2	0.0	0.0	0.0	0.0	0.0	0.0	261.0	194.5	397.8	0.0	553.9	2012.7	380.3	0.0	0.0	0.0	0.0	410.7	419.1	0.0	0.0	101.1	0.0	458.5	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.0	395.0	0.0	0.0	402.6	0.0	0.0	1143.7	0.0	0.0	0.0	0.0	0.0	0.0	592.2	0.0	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915980	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Distal tubular cells: 1520.3;Proximal tubular cells: 981.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		4000000	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	32.6	26.8	49.3	27.7	43.5	34.9	37.8	35.0	44.8	28.7	45.0	21.6	24.2	48.2	25.1	34.3	44.2	28.9	30.3	139.4	40.8	36.7	61.3	57.5	20.6	31.5	45.6	38.4	38.0	40.1	29.5	19.2	25.1	46.4	32.5	52.4	27.2	38.8	28.6	130.6	28.7	57.5	34.8	29.3	27.3	43.2	25.4	20.1	42.7	37.4	98.0	36.2	39.4	26.5	71.9	94.0	48.5	71.5	46.8	73.3	112.2	41.5	19.5	54.4	53.3	37.4	48.0	60.6	23.8	41.8	40.1	39.3	57.2	40.4	55.8	20.5	36.1	39.9	23.6	58.6	81.3	47.5	41.5	58.5	83.6	31.2	56.8	43.1	63.3	29.0	48.8	49.8	38.8	63.7	45.2	55.1	46.1	67.1	72.4	51.5	42.8	48.2	62.2	62.1	105.6	57.8	49.8	53.8	105.2	109.8	37.0	44.0	25.5	40.9	61.2	54.1	49.3	61.7	70.0	31.1	26.4	31.5	47.0	26.9	47.8	52.2	58.4	48.6	108.7	38.0	33.4	69.9	48.5	44.5	71.5	53.0	71.9	58.8	52.9	94.0	59.0	73.3	61.5	17.2	46.8	62.6	55.9	70.1	112.2	49.3	43.5	35.0	44.8	40.8	36.7	45.6	38.4	46.4	20.1	226.3	164.6	0.0	0.0	0.0	0.0	0.0	0.0	187.4	223.0	211.1	0.0	511.4	1520.3	335.0	0.0	0.0	0.0	0.0	367.3	532.1	0.0	0.0	105.8	0.0	543.7	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	380.5	0.0	0.0	302.9	0.0	0.0	981.3	0.0	0.0	0.0	0.0	0.0	0.0	453.3	0.0	0.0	0.0
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807044	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		970000	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	41.6	38.6	101.1	54.0	100.2	66.5	60.6	51.6	86.9	38.1	87.1	38.9	43.9	77.6	33.9	69.3	54.7	50.4	59.8	218.6	82.3	73.0	59.7	69.5	29.6	49.1	100.1	65.9	45.4	71.2	55.7	36.3	36.8	57.0	37.6	98.4	40.6	65.9	53.1	172.3	48.0	76.5	51.2	58.4	40.1	56.5	21.8	38.7	46.6	49.1	112.6	70.2	47.1	52.4	123.0	144.1	74.8	130.8	74.7	121.9	222.6	44.7	73.0	49.7	66.3	92.0	86.3	85.7	40.9	83.7	77.5	38.8	123.5	67.9	73.5	50.3	65.1	42.4	90.2	70.6	82.2	69.1	24.9	73.0	41.0	61.8	119.9	83.0	37.2	30.6	100.0	127.6	63.4	86.6	81.2	80.9	60.5	68.9	30.2	65.7	161.5	74.4	115.3	66.6	99.8	86.1	84.6	31.2	64.3	114.9	88.9	59.1	48.0	86.6	55.1	66.2	55.7	80.8	103.9	56.8	38.9	45.1	35.7	43.7	60.9	57.8	168.9	59.4	73.8	43.6	50.9	130.8	74.8	72.5	112.8	88.4	123.0	96.3	85.0	144.1	116.1	121.9	100.0	50.7	74.7	98.6	107.7	102.7	222.6	101.1	100.2	51.6	86.9	82.3	73.0	100.1	65.9	57.0	38.7	256.1	363.9	981.6	971.7	1003.2	230.7	3140.6	1197.4	362.7	382.2	600.2	123.7	1081.3	2332.7	965.7	464.1	701.9	2320.1	280.4	1145.7	924.4	671.8	956.9	507.1	1060.0	1395.9	200.2	970.5	596.0	1378.7	820.3	462.0	1118.7	1086.5	1424.7	1513.6	283.9	1228.5	1740.3	336.3	1959.5	260.3	349.3	760.4	345.7	304.0	1190.3	1239.3	852.8	1984.7	1551.2
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637888-31645006	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.7"	"Group enriched"	"Detected in some"	34	"Sertoli cells: 407.4;Smooth muscle cells: 177.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	11	"B-cells: 2.6"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	9.9	0.7	1.6	1.7	1.9	0.1	7.9	0.7	2.5	4.7	2.2	1.5	0.9	1.1	5.9	3.5	7.1	2.6	5.4	15.5	1.7	1.4	2.0	0.5	24.6	4.9	2.4	1.0	1.9	1.9	2.1	1.1	60.7	2.7	5.2	1.6	4.1	2.4	2.8	12.8	2.5	2.7	3.9	1.2	0.8	2.0	1.5	2.1	0.5	8.0	7.5	2.3	3.7	3.7	2.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.7	2.5	1.7	1.4	2.4	1.0	2.7	2.1	0.0	0.0	0.0	0.2	5.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	4.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	3.4	1.1	8.5	0.0	0.0	1.1	0.1	0.0	0.7	0.0	0.4	407.4	177.5	0.0	0.1	5.8	2.1	0.0	0.0	0.3
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 1647.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	35.1	39.1	48.5	42.3	29.9	34.6	53.4	32.0	28.3	41.1	38.4	43.6	44.6	80.7	39.5	27.6	50.0	69.6	114.5	46.5	34.4	45.6	106.8	66.9	40.8	54.0	37.5	76.4	42.1	35.0	50.6	25.6	58.1	28.2	48.0	55.9	61.4	54.9	41.0	27.7	63.7	58.8	51.5	71.5	58.0	59.4	46.5	93.7	60.0	59.5	71.1	30.5	48.5	72.9	100.2	55.3	36.5	62.4	32.4	31.1	29.4	38.8	50.8	62.9	115.4	89.4	33.4	101.4	28.3	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2	92.3	98.3	157.9	175.6	140.6	98.6	1647.0	242.0	117.8	108.1	162.3	37.3	430.9	1250.1	355.7	826.5	138.1	1074.0	93.5	379.0	409.1	121.0	226.5	102.6	381.0	504.7	87.4	443.2	110.5	242.1	581.7	92.9	227.7	237.8	426.6	815.4	91.5	365.2	768.6	80.6	703.8	110.5	90.5	143.5	367.8	236.9	139.0	427.4	165.8	1016.3	341.5
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.9	23.3	14.4	23.9	17.0	15.5	62.3	25.7	14.4	17.1	19.1	64.4	20.9	33.7	55.3	16.4	27.0	30.5	16.6	25.8	7.8	26.2	70.6	45.4	25.8	76.9	32.7	43.0	33.3	28.7	22.9	16.4	12.8	17.5	14.6	27.0	33.3	14.9	13.2	49.4	27.1	62.4	28.4	34.1	122.6	26.7	24.8	50.4	23.0	30.7	28.6	30.6	25.0	30.2	48.2	20.0	16.1	45.1	26.5	15.6	26.6	25.0	16.5	38.9	36.8	25.7	28.3	37.0	16.1	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0	205.4	224.6	375.1	495.2	343.3	204.5	3263.7	647.1	369.4	268.4	759.0	214.0	640.2	3068.8	479.5	156.4	370.1	2132.4	140.2	527.3	778.4	340.5	424.2	320.2	1125.6	767.8	133.5	711.5	338.8	489.5	270.1	325.7	488.5	865.4	798.1	1204.0	259.4	460.5	1508.0	286.4	1849.4	303.9	439.8	473.4	213.2	290.0	419.6	512.8	265.9	1320.1	744.1
COX6A1	COX6A	ENSG00000111775	"Cytochrome c oxidase subunit 6A1"	P12074	12	120438090-120440742	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062394	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA062394: AB_2684749"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.63e-2)"	49.2	48.0	171.0	32.1	103.0	52.6	43.8	44.4	107.5	37.3	96.8	38.5	32.4	102.8	28.0	47.0	59.3	41.8	37.6	41.5	121.5	92.0	85.8	102.6	32.4	39.6	140.0	57.9	27.7	62.7	43.8	38.3	44.4	86.9	43.1	74.3	31.3	63.8	44.2	10.6	37.7	85.7	38.1	67.2	32.1	60.8	28.1	61.2	33.7	48.2	36.0	40.1	42.1	35.0	74.5	102.2	60.5	69.8	47.8	87.4	83.0	47.2	101.2	57.6	60.1	44.4	37.9	70.6	30.1	40.3	53.5	45.7	122.3	48.3	99.6	90.1	42.5	41.4	79.1	56.1	66.1	34.7	59.7	121.0	53.4	57.9	89.5	41.1	58.5	38.4	45.5	81.6	48.8	57.9	44.2	45.0	72.6	52.3	31.2	44.4	132.3	84.4	148.2	52.5	92.1	148.4	57.7	38.6	93.3	84.4	114.0	76.0	66.1	55.2	54.2	70.7	33.5	97.2	66.9	33.9	33.4	41.3	34.4	41.8	48.5	66.6	77.1	52.4	57.4	44.4	38.5	65.5	58.3	54.4	69.5	58.5	74.5	64.3	59.5	95.1	59.2	59.1	59.3	60.5	47.8	69.8	102.2	87.4	83.0	171.0	103.0	44.4	107.5	121.5	92.0	140.0	57.9	86.9	61.2	369.2	267.5	329.6	423.0	340.5	204.2	104.8	682.8	548.7	311.7	734.5	543.9	662.2	1255.0	574.2	113.2	290.2	1336.6	93.5	578.7	601.6	281.6	433.2	262.5	840.8	680.4	138.2	495.4	264.6	384.0	100.3	279.6	388.0	497.7	739.4	694.0	232.4	574.7	1129.3	249.6	1194.5	252.8	336.3	428.1	355.7	331.5	339.1	775.3	316.6	860.7	644.8
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428428	"Predicted intracellular proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8"	"Cell type enriched"	"Detected in some"	64	"Cardiomyocytes: 3924.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	125	"NK-cell: 12.5"	"Lineage enriched"	"Detected in single"	125	"NK-cells: 12.5"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			3.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.8	0.1	0.0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	5.5	230.8	11.4	0.1	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3924.5	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	61.4	2.1	3.2	0.0	0.6	2.1	0.8	0.3	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.7	20.3	3.9	19.4	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648223-35658861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 2503.3;Distal tubular cells: 2530.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004192	Supported		Supported	Mitochondria		NA	NA		1200000	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	37.2	32.2	62.1	32.1	58.7	46.2	42.8	31.1	57.6	34.1	65.0	25.2	41.2	52.7	27.1	70.2	52.4	36.3	39.8	132.5	51.5	52.2	61.1	68.9	24.7	40.4	57.4	60.2	29.2	41.1	41.4	28.8	30.2	39.2	30.2	77.1	31.8	54.9	44.2	168.4	35.1	63.2	37.6	38.7	30.7	42.0	21.0	29.0	42.7	37.6	110.6	52.7	33.8	31.6	110.6	115.5	111.1	116.1	61.2	107.9	167.5	36.4	87.1	37.8	50.4	49.7	50.9	35.1	29.7	45.1	49.1	49.7	71.1	36.7	41.1	52.6	46.7	32.9	26.8	60.7	50.4	48.3	47.8	41.5	70.4	46.6	69.6	39.3	63.2	36.7	59.8	63.3	45.8	26.6	47.1	47.6	44.7	43.9	61.6	49.3	70.5	44.4	46.6	28.1	184.2	58.8	38.5	41.6	68.0	111.9	72.9	33.2	38.0	47.8	82.4	29.3	46.1	32.7	68.7	28.4	28.4	32.5	30.1	46.2	37.0	44.4	55.8	37.5	49.0	36.5	87.7	108.6	94.7	65.5	116.1	62.4	110.6	90.5	76.1	111.8	92.7	89.6	79.4	111.1	61.2	107.8	115.5	107.9	167.5	62.1	58.7	31.1	57.6	51.5	52.2	57.4	60.2	39.2	29.0	226.3	220.0	458.4	406.9	379.4	129.5	2503.3	772.0	354.7	217.2	663.0	60.9	533.3	2530.0	637.7	277.5	330.3	1579.1	210.2	701.4	649.3	430.6	454.9	274.7	1065.5	910.2	84.2	601.2	320.4	754.1	587.8	303.5	609.7	710.3	822.4	1028.9	175.1	735.8	1153.8	256.7	1262.3	137.8	258.7	388.3	116.9	177.2	494.3	560.9	394.4	1027.2	623.0
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.6;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.6	0.1	0.2	0.2	0.3	1.8	0.7	0.2	0.2	0.8	0.7	0.0	1.7	0.1	0.3	0.2	1.8	0.2	2.5	0.4	0.5	1.7	0.0	0.1	0.4	0.2	0.0	0.5	0.1	0.2	0.6	2.3	0.5	0.1	0.0	0.2	0.0	0.4	9.7	0.3	0.3	0.1	0.0	0.6	0.4	0.0	0.4	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3	0.0	0.3	0.0	0.6	0.5	2.1	0.4	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.6	23.6	0.0	3.2	0.0	0.6	0.2	0.4	0.2	0.0	0.0	0.1	3.2	1.2	0.0	0.0	19.1	0.6	0.0	0.0	0.0	1.3	0.9	5.6	3.5	0.0	0.0	4.1	0.0	0.0	77.8	1.3	0.4	0.3	0.0	4.4	2.5
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99894062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014295, CAB016244"	Enhanced		Supported	Mitochondria		NA	NA		53000	Mitochondria		"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	20.5	43.1	66.1	21.6	56.2	44.4	23.3	28.5	63.8	18.7	46.0	14.3	29.4	113.7	38.8	64.1	31.6	27.4	23.5	113.0	54.8	46.9	38.7	66.8	18.2	23.2	58.8	36.7	32.7	26.5	12.1	24.0	30.7	38.8	23.3	38.1	20.6	32.4	30.1	232.1	31.2	55.8	38.7	40.4	23.7	35.1	29.6	23.5	17.9	19.5	80.6	17.8	31.0	21.3	45.9	62.3	55.7	50.6	37.2	73.5	48.0	17.0	6.9	8.0	32.8	18.3	13.3	13.4	5.6	5.3	3.8	4.3	6.9	36.5	41.4	42.4	8.7	6.1	22.7	4.5	46.4	6.4	7.5	11.6	85.9	8.2	20.1	11.9	39.6	26.6	12.3	61.8	3.2	7.1	17.0	5.7	13.0	6.0	74.4	6.4	16.3	41.1	36.5	15.4	25.7	15.9	47.8	2.6	40.5	58.2	90.8	24.9	15.2	3.9	85.1	41.6	8.6	60.0	25.4	4.9	29.1	37.9	30.7	7.9	18.5	14.9	24.6	40.9	16.1	25.7	55.7	29.3	22.1	40.1	42.3	41.8	45.9	61.0	42.5	43.8	41.7	73.5	65.7	3.5	37.2	50.6	62.3	56.9	48.0	66.1	56.2	28.5	63.8	54.8	46.9	58.8	36.7	38.8	23.5	375.2	414.8	374.3	402.8	435.9	194.1	2063.7	626.8	575.5	377.6	574.0	96.2	831.0	1886.7	571.0	645.5	416.6	1532.5	303.7	739.7	730.3	697.7	423.0	347.2	1528.6	904.1	147.8	776.1	376.3	443.5	180.9	615.6	499.6	695.0	943.2	982.6	392.7	687.3	1094.2	552.3	1121.0	205.6	485.0	628.5	756.0	487.0	560.0	1492.7	393.7	1121.0	582.7
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152869	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 114.9;skeletal muscle: 404.3"	"Cell type enriched"	"Detected in many"	28	"Cardiomyocytes: 19391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8.0	0.8	2.6	2.0	3.9	6.1	6.6	3.1	5.0	114.9	3.3	2.4	5.0	1.6	4.0	2.7	2.6	4.6	4.2	3.5	6.0	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2.0	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7.0	4.7	0.0	1.3	1.4	1.9	0.0	0.1	0.3	0.1	2.6	0.2	0.0	24.5	18.0	0.1	16.5	13.7	0.5	0.0	0.0	0.8	0.6	6.9	25.1	0.0	0.3	0.0	0.0	0.1	0.1	0.9	0.1	0.9	0.1	16.3	0.0	0.2	16.9	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	3.7	0.0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.4	0.0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5	0.0	9.0	5.9	1.3	23.5	71.7	19391.7	25.5	1.4	3.4	21.0	43.2	1.0	693.0	10.8	13.4	160.8	0.0	0.0	12.2	0.9	86.2	2.4	43.9	4.4	18.4	63.5	0.0	239.4	11.6	76.0	207.9	6.0	269.9	0.0	0.0	16.2	9.2	0.0	264.5	128.7	56.3	181.1	233.8	1.5	3.2	16.7	1.6	2.5	0.0	0.6
COX7A2	"COX7AL, COXVIIa-L"	ENSG00000112695	"Cytochrome c oxidase subunit 7A2"		6	75237675-75250323	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"blood: 157.6"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 3729.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (8.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.73e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	26.9	25.3	49.7	18.8	55.3	26.5	30.2	27.0	54.9	19.5	55.9	12.3	37.0	35.3	16.9	41.5	29.7	20.3	23.4	76.3	38.0	32.9	44.8	51.7	17.8	23.9	48.9	34.6	12.6	46.9	19.4	27.2	18.3	36.8	24.0	61.5	18.3	35.7	27.1	38.2	19.1	35.6	29.0	39.4	18.1	36.4	62.8	27.5	17.4	22.4	47.1	27.1	23.4	16.7	109.1	130.5	94.1	108.8	76.9	110.3	157.6	15.3	35.2	46.2	37.9	27.6	31.4	33.5	37.5	34.5	37.5	40.7	63.3	23.5	25.1	33.3	33.8	50.5	33.4	32.1	40.5	47.0	45.8	65.9	37.6	110.1	83.1	28.4	40.0	44.4	33.9	54.3	34.6	22.7	39.5	43.4	57.2	33.2	36.5	50.6	71.4	17.0	43.6	29.0	75.8	64.5	27.8	23.3	66.0	59.7	100.2	31.6	38.3	23.3	42.8	37.6	39.6	26.1	113.0	21.1	16.6	30.3	13.2	42.5	51.7	56.3	27.8	18.9	45.8	32.3	92.9	100.0	94.1	78.3	107.7	83.0	109.1	102.4	93.5	103.6	90.2	101.1	93.4	74.7	76.9	108.8	130.5	110.3	157.6	49.7	55.3	27.0	54.9	38.0	32.9	48.9	34.6	36.8	27.5	282.9	318.7	403.4	476.4	491.8	218.2	2259.4	751.6	480.5	353.8	478.1	113.9	585.5	2205.0	700.7	3729.3	440.0	1510.8	210.2	878.7	682.4	432.2	710.6	290.2	1241.2	769.2	146.2	637.2	364.0	458.4	2761.1	329.4	416.4	803.1	743.0	1103.4	253.8	951.9	1195.4	318.9	1303.8	241.1	401.0	739.2	2380.3	194.6	547.7	684.3	381.3	1038.8	776.7
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899438-77907373	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.4"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 2170.2;Distal tubular cells: 1934.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA058041	Uncertain					NA	NA					"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favorable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (2.43e-4)"	9.4	11.5	23.7	9.2	26.8	18.0	18.2	15.4	32.3	13.1	22.5	4.1	19.8	18.0	8.1	16.4	17.1	10.4	10.7	81.4	21.9	20.6	34.6	28.8	9.7	9.9	24.0	22.9	7.2	15.1	11.1	11.7	8.6	21.3	9.6	22.9	6.9	14.5	18.1	69.4	9.2	19.7	15.9	19.0	8.1	14.5	3.0	12.9	4.8	12.2	62.7	10.8	11.3	9.7	16.5	23.0	19.4	25.9	17.2	22.2	19.1	8.0	20.5	11.8	12.0	13.3	11.3	8.0	6.6	10.3	13.1	15.3	23.9	13.7	12.5	10.1	10.9	12.6	13.2	31.7	18.3	15.5	5.6	31.1	13.6	29.1	22.7	11.1	21.2	8.6	14.4	15.5	15.7	13.9	8.4	13.9	8.2	15.6	22.6	14.0	23.8	12.7	20.5	12.0	38.5	55.9	11.5	17.4	34.5	35.6	26.1	11.4	7.4	17.2	22.3	10.5	10.0	8.6	11.5	9.2	5.9	8.7	12.9	5.8	5.0	13.0	15.6	13.8	28.3	7.6	19.4	20.8	14.0	15.6	25.9	21.1	16.5	20.1	19.0	23.0	13.4	20.7	22.2	15.5	17.2	24.5	17.1	18.4	19.1	23.7	26.8	15.4	32.3	21.9	20.6	24.0	22.9	21.3	12.9	125.0	164.5	253.2	284.4	264.2	96.9	2170.2	624.2	230.2	216.1	350.7	33.4	385.6	1934.8	387.0	16.0	214.7	1219.2	420.4	345.1	332.3	226.1	262.9	221.6	970.7	631.3	44.5	495.8	200.1	437.7	23.1	184.6	371.7	511.2	421.2	729.5	113.4	365.0	764.5	165.9	1221.3	122.9	207.0	327.3	45.0	113.1	302.1	494.9	208.8	796.8	406.4
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909235	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"testis: 43.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 328.3;Late spermatids: 134.7;Spermatocytes: 292.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 28.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA												"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	3.4	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.1	0.0	0.4	0.1	0.0	3.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.7	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	292.2	34.5	0.0	0.0	0.0	0.0	0.0
COX7C		ENSG00000127184	"Cytochrome c oxidase subunit 7C"	P15954	5	86617904-86620962	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 298.4"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 4397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046647	Approved					NA	NA					"HPA046647: AB_2679736"	"unprognostic (1.45e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.46e-2)"	43.3	60.4	76.4	35.7	68.1	36.8	49.6	41.1	65.0	35.0	74.8	22.7	44.0	76.0	50.7	55.5	53.7	32.6	44.4	150.2	61.8	57.6	91.6	83.1	36.0	66.1	72.0	44.2	51.9	88.8	39.3	47.3	26.5	51.5	42.7	53.9	36.2	127.6	46.1	298.4	28.0	73.3	71.5	39.7	35.5	54.2	31.2	32.1	39.7	56.3	84.9	40.1	53.9	58.0	92.8	91.6	54.1	73.4	51.2	96.5	113.9	55.5	64.2	57.7	107.6	53.9	54.3	64.7	43.2	34.7	28.7	40.6	74.5	101.3	75.7	47.3	31.9	78.1	60.6	51.0	82.1	47.1	56.1	78.3	60.5	99.2	76.9	45.1	71.9	72.2	63.5	70.8	36.5	50.2	82.4	45.8	66.0	36.6	89.1	41.9	110.9	74.5	90.7	61.3	55.5	185.9	72.5	67.3	139.2	85.7	106.5	72.0	52.6	41.5	97.8	91.1	65.6	99.3	98.1	45.3	26.7	49.0	45.7	82.5	86.4	99.9	87.4	68.5	84.2	50.4	38.0	72.1	54.1	58.1	73.4	72.5	92.8	91.1	71.8	91.6	79.4	96.5	84.2	7.3	51.2	68.2	85.2	80.2	113.9	76.4	68.1	41.1	65.0	61.8	57.6	72.0	44.2	51.5	32.1	476.4	561.1	1097.3	719.7	642.7	245.3	4397.0	1722.3	686.6	645.0	1151.5	147.3	1042.4	4003.9	1050.4	765.0	580.9	1905.7	373.8	1318.7	727.2	613.8	874.5	590.4	2267.2	1206.0	217.7	881.2	710.8	1215.4	325.7	912.7	888.1	1057.8	1208.3	1577.3	394.4	1159.8	1813.1	677.5	3328.8	216.7	588.6	707.6	958.9	346.1	817.7	1104.6	792.5	1997.9	1118.8
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974607-63976543	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.5"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1984.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055942	Supported					NA	NA					"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	41.4	42.8	54.0	32.8	53.4	50.4	47.4	40.9	60.3	30.2	76.6	18.2	35.5	69.0	23.3	31.2	63.3	35.9	43.9	154.9	41.5	41.0	78.8	61.1	38.1	50.8	54.5	34.0	24.7	43.0	38.7	37.6	32.2	35.7	37.9	51.6	35.9	54.4	50.2	275.5	31.2	66.7	29.9	37.0	31.0	50.8	18.7	24.3	44.6	42.4	121.7	34.8	38.8	29.8	52.7	114.8	87.8	108.6	51.0	75.7	80.3	60.3	80.6	52.0	51.6	22.3	27.3	37.7	32.0	35.9	63.6	49.5	53.8	49.6	28.8	70.9	44.5	60.2	60.3	40.0	55.1	21.8	42.3	69.5	41.9	65.4	63.1	35.8	42.2	54.6	35.2	41.9	50.9	41.1	28.4	39.4	68.6	48.7	62.8	39.9	157.1	59.7	143.7	47.3	72.0	141.6	46.8	41.8	121.1	51.4	51.0	47.2	66.8	38.1	55.4	78.5	23.2	81.4	45.9	24.2	37.0	50.2	79.2	37.3	78.9	61.8	44.4	48.1	41.7	44.3	78.3	101.8	87.8	57.5	108.6	42.4	52.7	63.2	56.4	114.8	46.4	49.0	53.4	71.3	51.0	97.9	113.0	75.7	80.3	54.0	53.4	40.9	60.3	41.5	41.0	54.5	34.0	35.7	24.3	208.4	199.1	288.8	299.8	261.7	169.3	1162.0	458.6	376.1	244.5	415.2	68.7	392.2	1984.5	389.4	7.0	198.9	1123.7	140.2	421.4	448.5	223.4	381.0	221.4	677.3	801.9	101.7	693.6	209.3	461.0	13.2	221.8	429.5	595.5	445.4	846.8	231.3	439.3	874.7	207.9	1094.8	128.1	155.2	347.5	51.9	59.0	324.2	306.9	320.7	910.0	526.5
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347191-93348356	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	72	"testis: 72.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"U-937: 18.0"					"Not detected"	"Not detected"			HPA003127	Approved					NA	NA					"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	72.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	811.2	0.0	0.0	0.0	0.0	10.6	0.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1407.4	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	0.0	19.4	0.0	393.6	80.8	0.1	2.9	0.0	0.0	0.1
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 693.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 151.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA		110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.5	13.4	28.0	11.1	12.4	25.9	12.8	15.7	32.7	21.5	35.3	27.9	31.6	29.0	17.1	15.9	33.0	29.3	25.4	12.3	19.3	38.8	33.9	42.7	32.3	20.0	20.0	22.1	18.0	31.9	20.8	41.4	11.0	19.0	21.9	30.8	28.2	17.1	80.0	37.4	18.5	15.6	62.7	151.5	33.0	18.0	55.3	26.9	35.9	36.1	15.9	35.8	49.5	26.3	7.7	40.7	30.7	14.4	20.9	44.6	23.0	39.0	31.4	22.8	23.4	26.6	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5	17.9	24.8	104.2	137.8	138.6	109.2	340.1	175.8	33.5	25.0	75.0	76.6	235.5	693.0	191.2	55.0	98.8	477.2	70.0	250.0	197.5	112.8	124.7	59.9	203.6	217.6	82.6	140.6	55.3	91.9	71.2	82.3	127.4	170.4	267.9	288.6	98.9	227.1	319.6	85.2	391.4	75.4	71.1	158.3	73.6	93.6	143.2	198.1	79.6	481.1	207.2
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.9	28.7	37.5	26.4	30.5	34.2	30.7	31.8	40.7	36.6	26.5	26.2	25.9	55.9	92.3	36.6	39.9	43.8	18.0	39.8	26.1	36.7	21.9	37.9	29.7	21.4	34.7	17.3	28.9	18.8	34.5	11.8	37.6	38.0	35.0	34.3	7.8	31.7	18.5	40.5	10.8	34.4	29.6	48.9	37.7	70.2	24.9	12.6	39.9	91.2	36.1	57.7	46.9	40.2	20.2	33.4	22.7	29.2	31.8	18.6	38.1	45.1	24.1	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8	53.6	38.2	49.8	84.3	47.5	12.6	330.7	79.0	33.5	34.2	34.9	21.6	240.1	177.4	96.7	9.4	51.7	207.6	70.0	73.2	147.6	65.4	64.8	37.0	330.0	115.9	50.9	62.8	52.2	76.6	5.4	55.0	77.4	54.0	158.7	117.7	20.6	89.9	152.0	54.8	301.8	18.1	45.3	63.7	39.6	31.3	49.9	251.0	56.8	156.2	138.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1022.8;Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 183.6;OE19: 84.6"					"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.0	33.8	4.7	12.9	15.0	17.6	7.5	8.9	6.9	7.2	7.2	28.4	21.5	13.1	9.1	14.3	3.8	11.6	9.3	19.0	2.2	19.5	36.2	10.3	20.7	183.6	16.5	9.8	7.7	27.3	5.7	9.8	10.1	9.1	6.1	12.9	15.4	14.7	9.3	26.5	10.2	9.3	3.0	84.6	41.9	11.4	12.6	24.5	9.9	15.0	10.5	5.1	19.7	5.6	10.1	3.5	14.7	9.5	8.6	7.6	7.9	8.1	8.1	22.6	13.7	11.6	38.5	14.6	19.4	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9	74.5	84.5	90.8	84.9	57.8	71.3	216.3	254.8	84.3	67.1	115.1	29.5	201.1	484.1	142.6	109.5	67.1	494.9	140.2	122.3	163.1	89.1	73.5	87.6	1022.8	188.0	41.3	161.8	136.9	151.1	228.9	99.5	69.4	271.7	69.5	259.6	93.2	146.4	263.1	107.5	1001.5	53.3	97.0	80.2	54.2	48.9	55.7	133.9	91.6	302.4	92.8
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 138.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA					"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.7	3.6	6.0	10.8	25.9	15.5	2.9	10.1	10.2	7.5	7.3	2.0	12.7	14.0	2.2	12.2	7.8	6.7	11.5	10.1	10.6	22.2	8.4	12.8	8.2	3.4	11.3	11.0	12.3	14.3	12.7	8.1	6.9	11.5	14.6	9.5	7.1	26.5	12.0	5.9	10.7	5.5	2.3	16.9	8.8	8.6	2.0	9.8	11.2	5.0	9.1	3.5	10.1	20.2	9.6	5.7	13.7	8.5	6.5	6.1	3.1	8.9	5.2	14.9	18.5	9.5	12.6	9.3	6.5	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4	11.9	9.3	20.1	42.9	29.3	26.0	138.5	12.7	10.7	12.5	17.4	60.9	18.8	24.9	11.1	2.6	18.0	45.5	46.7	10.2	7.3	20.8	16.4	4.7	70.6	11.7	23.8	17.2	12.3	7.8	3.6	21.3	13.7	8.5	7.2	18.2	11.7	10.7	23.7	22.3	23.7	43.8	32.3	23.1	37.2	33.4	32.2	35.9	18.3	21.5	33.8
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461834-124617888	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 106.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 103.7;Late spermatids: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		880000	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	9.6	14.2	37.3	6.0	34.0	6.9	7.9	11.9	34.2	12.3	13.6	29.7	8.2	17.9	7.5	11.0	12.7	8.1	8.3	9.8	43.0	31.5	18.6	33.8	6.6	8.2	62.7	19.3	5.5	12.2	6.6	5.6	7.2	20.5	6.9	6.7	6.7	13.3	10.6	6.5	8.9	15.7	8.1	106.0	8.2	12.4	14.2	19.5	7.1	20.5	3.6	11.2	8.7	5.7	24.7	20.0	13.3	16.1	3.9	17.2	12.9	14.8	7.4	3.0	7.6	11.7	9.6	8.0	5.5	11.2	3.5	6.4	1.3	13.8	14.7	12.8	8.2	3.8	16.2	0.9	2.9	3.6	3.3	10.6	10.8	2.4	6.8	12.0	2.1	17.5	7.1	12.6	3.4	8.3	10.2	5.5	13.3	5.3	5.9	4.3	14.7	7.1	6.9	5.3	6.3	4.2	7.6	3.3	18.8	7.5	1.9	1.7	9.1	3.8	14.1	5.0	4.3	10.7	0.3	2.6	5.4	8.0	4.5	1.4	4.9	1.5	4.7	4.9	4.2	1.2	4.6	16.1	13.3	9.5	13.5	12.4	23.7	11.1	10.1	20.0	24.7	13.7	9.6	2.7	3.9	14.9	7.5	17.2	12.9	37.3	34.0	11.9	25.0	43.0	31.5	62.7	19.3	20.5	19.5	3.0	15.0	15.6	9.1	6.5	6.2	12.0	15.3	18.7	12.5	7.0	0.0	44.1	28.2	4.0	103.7	1.6	23.3	0.0	2.1	20.7	9.3	7.6	10.4	53.3	22.8	11.1	9.1	7.4	13.2	124.0	5.5	9.2	16.9	14.4	17.3	6.9	3.5	25.9	9.9	58.6	6.4	12.9	5.1	28.8	10.2	4.6	20.3	7.2	19.6	11.1
MT-ATP6	"ATP6, ATPase-6, MTATP6, RP, Su6m"	ENSG00000198899	"Mitochondrially encoded ATP synthase membrane subunit 6"	P00846	MT	8527-9207	"Disease related genes, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 419.0;skeletal muscle: 475.3"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 108059.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 419.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1186.6"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (2.97e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.64e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-3)"	85.2	89.2	126.0	25.1	159.3	20.1	29.6	45.2	81.2	20.1	60.3			75.6	23.5	30.9	42.8	19.8	24.6	309.5	122.3	90.2	154.4	166.8	18.0	19.3	102.8		26.5	54.7	36.2	22.0	34.1		37.6	59.4		66.8	35.6	475.3	62.5	52.6	27.9	61.3	20.7	58.4	27.7			22.4		18.6	23.0	15.7	110.2	58.9	419.0	88.2	72.3	90.5	35.3	100.8	166.4	116.2	182.2	221.8	50.9	75.9	148.7	27.1	20.1	34.0	195.6	110.9	179.7	63.2	80.2	31.2	219.8	12.1	116.0	37.3	128.3	105.3	157.3	1186.6	338.6	37.7	93.1	203.9	83.0	102.9	36.1	34.9	141.5	35.7	100.8	103.4	131.1	78.3	284.0	57.3	247.9	30.5	77.4	68.9	72.2	49.5	110.7	208.9	256.0	66.4	85.2	53.3	113.7	107.5	199.3	121.6	319.6	188.2	82.0	121.2	135.4	106.1	58.0	76.5	124.6	71.6	198.7	45.8	419.0	88.2	156.1	56.6	66.3	71.6	106.0	64.7	71.1	47.5	110.2	76.5	90.5	100.1	72.3	67.8	58.9	47.6	35.3											1381.7	1526.0	11633.9	5315.5	2578.7	0.0	108059.0	10741.3	2731.6	2651.3	6092.6	0.0	0.0	1593.2	1756.2	808.5	1505.8	13591.3	14997.7	2949.2	0.0	1371.6	3985.7	1952.8	21340.2	0.0	0.0	3847.9	7623.7	10387.2	3622.6	7103.8	2816.3	2404.1	3082.2	11928.5	0.0	2519.5	9780.9	4668.2	10316.3	0.0	6202.4	2943.8	6022.8	4841.7	2653.0	0.0	6498.2	11027.9	6485.3
MT-ATP8	"A6L, ATP8, MTATP8"	ENSG00000228253	"Mitochondrially encoded ATP synthase membrane subunit 8"	P03928	MT	8366-8572	"Disease related genes, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 959.7"	"Cell type enriched"	"Detected in many"	31	"Cardiomyocytes: 20663.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 352.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 352.9"	"Cell line enhanced"	"Detected in all"		"HeLa: 805.0"															NA	NA						"unprognostic (1.54e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.56e-5)"	"unprognostic (5.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-2)"	257.8	128.5	111.1	33.5	124.1	20.5	31.2	42.1	82.1	14.9	78.9			115.5	23.9	11.6	31.6	14.4	19.9	203.6	108.7	78.8	151.5	165.2	16.9	18.5	88.8		24.3	56.4	22.8	21.1	27.7		44.2	38.7		65.2	25.7	959.7	33.1	91.5	14.2	52.0	19.3	67.4	26.1			23.2		11.8	19.6	15.4	87.7	58.0	352.9	78.1	75.9	79.1	24.2	189.4	69.9	228.3	43.4	248.7	39.8	112.1	398.9	23.6	18.1	31.7	81.2	127.3	485.5	99.6	85.8	69.2	326.0	14.0	131.5	28.5	214.5	91.1	367.2	805.0	183.1	45.4	213.8	314.4	85.5	69.8	40.2	34.6	254.6	25.8	193.9	194.4	154.0	55.5	101.3	125.2	315.4	50.2	106.8	50.5	103.4	111.0	102.1	133.6	189.5	71.8	129.8	151.3	140.3	147.4	378.1	136.9	449.1	377.2	88.4	195.8	194.6	182.8	104.4	174.8	277.5	87.1	380.3	53.6	352.9	78.1	97.9	49.4	68.6	73.5	87.7	55.9	58.5	47.2	87.3	68.9	79.1	49.0	75.9	68.0	58.0	44.0	24.2											175.7	127.6	194.5	6.6	10.3	0.0	20663.1	265.0	662.5	619.9	12.2	0.0	0.0	3.3	11.5	6.0	7.1	98.6	420.4	26.4	0.0	6.7	3.9	274.2	625.8	0.0	0.0	28.0	241.2	345.1	31.7	37.7	12.6	11.8	11.8	48.6	0.0	16.1	47.0	23.7	20.3	0.0	38.8	11.3	24.7	22.2	8.0	0.0	192.9	46.4	6.2
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 81405.0;Enterocytes: 59874.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 872.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	114.5	173.2	235.7	256.3	540.3	247.5	249.9	261.4	87.1	66.0	110.6	208.4	373.6	302.7	125.7	198.6	65.0	435.2	26.9	231.6	94.6	143.0	165.0	181.7	872.7	389.9	74.8	104.9	230.2	288.6	241.1	65.3	145.0	306.7	79.4	172.7	115.3	217.3	195.5	277.4	85.7	469.5	59.9	156.0	141.8	112.3	70.4	181.6	334.7	303.0	112.7	150.2	90.6	351.3	163.0	296.6	201.5	352.9	316.5	264.7	180.2	259.8	131.1	103.0	98.6	68.6	130.7	276.7	128.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5											2694.8	3022.9	23660.6	9171.4	8678.3	0.0	81405.0	28094.1	4463.5	5243.5	18590.0	0.0	0.0	3606.0	6482.3	1224.4	4243.1	59874.1	34807.7	4485.9	0.0	3116.3	8181.6	3594.1	45857.2	0.0	0.0	7240.0	18002.1	27410.8	6497.0	10830.0	8032.7	6539.1	13021.9	32338.6	0.0	5722.6	29051.7	7980.9	24852.9	0.0	13394.3	6634.5	9840.4	12887.5	10030.7	0.0	18830.6	25753.2	17251.8
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 489.9;skeletal muscle: 343.4"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 412590.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1073.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		1300000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27.0	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56.0	343.4	56.4	51.1	40.0	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	111.2	179.1	238.3	230.3	487.6	188.0	175.6	145.1	117.7	82.5	124.6	192.6	251.5	232.6	121.5	213.4	84.9	422.7	31.5	298.5	111.8	180.1	161.5	166.8	1073.7	370.2	106.1	140.2	187.4	275.7	441.7	42.5	152.4	270.3	91.3	232.4	155.7	226.9	226.0	240.8	102.5	404.1	62.3	220.6	114.0	107.2	72.6	194.8	336.5	310.9	89.2	147.6	119.5	294.8	209.6	367.9	205.2	568.6	225.1	200.0	173.5	188.5	102.0	115.3	114.6	131.1	106.4	283.3	131.3	489.9	409.1	476.0	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4											1343.0	1746.9	18282.0	6995.6	5999.6	0.0	412590.4	19500.5	2813.3	2462.5	17642.7	0.0	0.0	3143.4	3272.8	866.0	2789.7	27604.7	22029.3	4281.1	0.0	1817.5	4991.0	2029.2	43011.4	0.0	0.0	6162.7	12438.4	17929.8	4401.0	7095.7	4687.5	4875.7	4595.3	21499.4	0.0	3881.8	14501.3	4815.7	15512.8	0.0	6946.2	3920.2	6682.3	8100.4	5859.1	0.0	11198.1	21247.6	11593.6
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 319.5"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 76804.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 810.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA					"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	56.5	83.7	174.1	20.5	149.4	34.8	55.5	47.4	106.2	30.5	90.9			76.1	27.5	46.0	40.4	26.3	28.7	290.4	159.6	111.4	190.3	143.1	21.0	22.8	120.2		27.9	38.9	60.5	26.7	32.5		37.3	95.5		79.0	64.3	319.5	70.0	55.3	39.0	61.9	21.7	60.5	36.5			31.0		31.0	26.9	18.7	247.1	126.7	244.3	245.3	141.7	181.1	106.8	130.8	155.4	238.8	339.1	475.8	196.3	130.7	170.6	101.1	67.4	104.1	208.0	195.6	292.9	73.9	141.6	73.7	359.5	37.6	204.9	119.5	99.3	164.3	155.7	810.6	345.5	96.2	92.6	205.1	188.5	291.4	74.1	110.5	238.7	124.6	168.0	123.3	296.8	222.5	267.4	94.0	540.0	53.0	208.4	112.2	100.6	75.3	211.0	420.2	231.5	107.0	148.6	79.5	87.1	164.8	347.1	182.0	408.6	199.6	113.0	193.8	211.0	111.3	122.2	78.6	163.5	112.8	302.0	74.2	132.0	245.3	121.5	110.0	128.3	137.4	198.7	119.5	127.0	126.7	247.1	153.2	181.1	244.3	141.7	122.3	107.8	79.5	106.8											1774.7	2343.8	18268.7	8249.8	7411.8	0.0	76804.5	19304.4	3075.6	3885.5	15697.2	0.0	0.0	3702.1	4549.9	1673.9	3293.3	31596.9	21118.2	5876.9	0.0	3002.6	5473.3	1979.3	30765.6	0.0	0.0	6556.1	11050.6	17592.2	7669.6	10722.1	5677.4	5267.0	6541.2	23740.6	0.0	4985.0	16907.1	7340.6	25199.2	0.0	11945.6	6322.1	9983.2	10814.8	7412.6	0.0	11568.9	24590.7	11079.5
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 324.2;skeletal muscle: 302.1"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 61379.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 490.3;HeLa: 493.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400, HPA074796"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: "	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	78.0	52.4	98.5	14.7	143.5	14.4	32.3	38.4	59.6	30.9	54.0			55.6	25.0	43.6	28.0	25.0	21.2	222.5	93.9	68.0	128.7	144.7	19.6	13.7	83.6		25.3	51.4	33.6	23.7	32.6		32.9	57.7		59.2	49.5	302.1	63.5	37.2	37.4	44.3	15.7	55.2	20.2			20.9		20.6	23.6	14.7	183.7	78.7	324.2	155.7	90.0	146.7	57.6	73.4	99.2	123.0	131.3	490.3	78.9	99.1	84.7	35.1	22.2	38.5	97.6	162.5	188.2	41.5	100.3	26.6	231.5	18.2	104.1	54.5	91.9	81.5	105.1	493.3	174.0	92.4	59.0	128.5	170.3	155.3	42.0	90.5	150.2	56.2	76.8	53.7	118.5	113.1	202.8	54.8	121.7	27.3	71.8	67.4	64.8	48.4	117.8	176.2	171.6	43.9	77.6	59.0	111.5	83.4	192.8	162.6	203.7	176.1	77.9	101.9	141.8	65.0	32.5	43.6	80.6	46.8	92.0	48.9	324.2	155.7	235.1	102.8	94.4	135.3	150.5	118.7	132.0	78.0	183.7	128.3	146.7	148.0	90.0	96.8	78.7	79.8	57.6											1101.8	1182.9	10535.1	6605.8	2949.0	0.0	61379.6	10280.2	2941.7	2205.5	7087.1	0.0	0.0	1833.6	2297.4	679.0	1928.7	15168.1	14904.3	3076.0	0.0	1463.9	4337.7	1777.7	14746.0	0.0	0.0	2756.0	7288.5	8580.4	3048.7	7355.0	2431.1	2478.3	3811.6	11241.0	0.0	2672.3	10113.2	5078.0	11513.5	0.0	5704.4	3210.7	4468.4	3767.8	2992.1	0.0	6827.7	9828.0	8723.5
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 314.4;skeletal muscle: 398.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 72531.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 314.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 314.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 673.1"	"Low region specificity"	"Detected in all"							"CAB033779, HPA066847"	Approved					NA	NA					"CAB033779: AB_2149736, HPA066847: "	"prognostic favorable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	83.5	48.0	118.0	15.2	136.1	17.7	31.8	45.0	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96.0	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45.0	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	101.9	104.3	85.6	77.9	325.0	59.2	110.1	88.0	26.0	24.4	25.8	181.3	111.3	125.2	56.0	66.3	24.8	68.2	9.4	53.0	49.0	89.2	73.5	139.3	673.1	257.0	69.8	65.9	137.7	140.2	144.8	37.8	54.6	99.7	26.2	36.7	64.0	78.3	72.4	140.2	53.0	273.1	22.9	64.3	78.6	55.9	38.9	67.2	135.5	165.5	35.6	56.7	48.8	78.1	85.3	108.9	69.7	228.7	137.9	81.8	73.9	104.2	73.1	86.9	53.5	58.0	55.0	116.9	22.3	314.4	54.4	103.0	25.7	31.4	37.3	54.3	30.8	34.0	20.6	60.8	41.1	46.4	157.8	35.8	32.0	32.2	22.0	19.5											1256.6	1138.7	6703.3	2831.5	2012.7	0.0	72531.4	10000.0	1801.4	2082.6	4374.0	0.0	0.0	875.4	1190.4	925.4	1519.1	10706.5	9881.7	3135.3	0.0	1058.8	2565.3	1330.0	13675.3	0.0	0.0	3018.7	7368.9	9328.1	4287.1	6527.3	2029.2	1420.6	1887.4	12938.3	0.0	1718.0	6638.7	3334.2	5210.0	0.0	6305.8	2437.5	5090.3	4626.8	1812.2	0.0	3284.5	11055.0	4223.0
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 432.3"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 49093.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in all"	5	"basophil: 432.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 432.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	93.0	57.2	116.0	16.9	169.9	15.6	33.9	40.1	73.5	22.6	53.7			50.1	21.5	59.8	29.0	22.1	19.3	262.4	112.2	85.2	125.9	128.9	20.9	14.7	113.0		25.1	62.0	24.3	20.3	37.0		28.1	59.0		85.3	41.0	263.4	72.7	39.2	24.6	72.4	15.2	49.2	27.3			18.2		17.7	23.8	13.1	66.1	43.5	432.3	54.8	43.0	57.9	21.8	94.6	104.2	93.3	157.4	337.2	60.2	88.3	88.4	22.1	23.6	29.9	131.2	128.0	135.9	84.1	63.4	38.9	170.0	14.6	110.5	51.2	118.3	75.9	156.8	612.6	211.5	69.1	152.0	182.5	99.4	202.0	58.1	57.6	84.5	34.7	75.0	114.3	133.2	56.7	111.9	86.3	246.1	46.8	99.5	68.3	75.8	52.3	113.9	175.1	146.5	58.4	70.0	38.2	117.4	140.8	155.7	180.7	175.9	109.6	88.9	110.1	125.0	111.9	87.1	74.6	114.4	57.7	131.3	39.7	432.3	54.8	93.1	34.1	39.7	54.7	58.6	39.5	42.5	23.0	66.1	48.5	57.9	88.6	43.0	45.7	43.5	25.9	21.8											854.6	571.9	9056.6	6978.7	2368.7	0.0	49093.4	9352.8	2568.3	1610.6	5912.8	0.0	0.0	1531.9	1483.8	1182.4	1676.0	12590.8	16329.3	3187.2	0.0	1222.0	4063.7	1766.1	15003.8	0.0	0.0	3057.2	8326.4	10199.3	4945.8	8393.1	2380.5	1572.4	3231.9	13237.7	0.0	2288.2	10285.9	4266.6	9047.2	0.0	7166.1	2550.6	5515.5	4332.8	2146.6	0.0	6221.6	10985.9	6668.6
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 33020.6;Erythroid cells: 20674.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 644.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	85.5	139.7	93.3	91.5	644.7	129.2	77.7	72.1	42.4	39.1	44.3	210.2	133.3	89.1	111.9	92.5	70.8	178.3	40.1	157.5	67.3	127.7	192.1	87.6	465.1	346.0	100.6	129.0	132.7	223.4	292.0	65.5	73.9	233.9	60.8	102.4	69.0	104.2	73.7	279.5	67.7	172.2	47.9	245.4	129.3	58.7	91.7	82.0	237.9	236.2	38.5	83.7	34.8	69.8	142.5	254.3	161.5	208.4	103.2	60.5	91.9	105.1	77.0	40.5	53.1	192.1	49.1	78.4	34.2	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4											652.1	738.1	6543.7	1904.3	1765.5	0.0	33020.6	8848.3	2785.1	1856.3	4782.3	0.0	0.0	986.5	1173.3	880.9	872.1	11850.5	20674.5	2500.6	0.0	790.1	1401.0	1375.6	14769.6	0.0	0.0	2746.0	8921.3	11655.5	4356.4	8457.2	1642.1	1763.0	2463.5	12873.7	0.0	1918.1	9893.1	4573.5	7467.5	0.0	6887.9	1962.1	6063.0	3539.9	1651.0	0.0	4305.8	10869.3	1952.0
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 392.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 130137.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 821.0"	"Low region specificity"	"Detected in all"							HPA053928	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41.0	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26.0	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53.0	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40.0	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821.0	271.8	49.3	113.1	134.0	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257.0	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81.0	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148.0	93.0	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89.0	87.6	67.6	53.0											1179.2	1324.7	15760.8	7514.4	3912.5	0.0	130137.0	15452.1	2295.3	2103.1	12148.5	0.0	0.0	2064.1	2636.7	917.0	2449.9	17720.8	23127.3	3538.6	0.0	2017.3	5309.0	2067.8	31565.1	0.0	0.0	4902.7	11944.3	15339.0	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0.0	3353.9	12846.0	5441.2	13683.6	0.0	6208.8	3859.5	7259.5	5529.7	4316.1	0.0	9799.9	18174.2	10097.1
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 16050.3;Hepatocytes: 4100.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 885.9"	"Low region specificity"	"Detected in all"							HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	97.1	90.4	163.1	166.1	571.6	120.3	71.9	208.6	52.3	32.7	59.8	150.2	89.8	241.1	85.5	140.9	53.6	185.3	25.3	223.3	65.2	94.9	104.4	173.3	885.9	279.0	83.9	178.2	155.8	210.6	228.8	62.4	218.5	246.4	65.5	125.0	95.5	172.9	119.9	173.6	67.7	228.6	41.1	103.4	109.2	39.3	70.3	107.2	174.1	205.2	49.5	67.0	102.3	162.1	69.9	366.4	115.3	224.3	209.4	86.0	107.1	125.8	79.8	156.5	73.2	128.4	61.7	242.4	40.1	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8											208.4	153.9	1221.6	193.7	203.1	0.0	16050.3	1630.6	940.9	684.7	307.1	0.0	0.0	76.3	127.4	46.0	141.8	949.6	2499.6	297.1	0.0	116.0	126.2	448.0	4100.6	0.0	0.0	246.6	1665.3	1966.8	217.5	386.3	249.3	243.0	242.5	657.8	0.0	237.0	573.3	217.1	415.7	0.0	342.8	211.1	226.8	167.2	211.8	0.0	631.2	458.3	137.0
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 21708.1;Hepatocytes: 6052.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 367.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	47.2	30.4	71.2	14.8	94.5	11.3	16.5	23.2	45.8	13.6	30.3			38.9	16.6	24.9	26.2	21.4	19.1	190.3	65.0	52.8	56.3	66.6	19.3	9.4	56.1		18.6	22.9	23.1	7.9	15.1		27.5	28.0		25.7	21.5	223.2	63.9	29.5	25.3	37.9	12.6	41.4	14.6			12.8		13.2	24.9	8.0	124.1	89.3	193.9	123.4	79.6	99.3	33.7	70.0	74.7	91.4	88.3	276.3	72.4	49.3	144.0	22.1	16.2	27.1	109.7	92.4	170.5	73.1	67.2	18.2	150.6	8.5	75.6	27.0	95.4	58.2	124.9	367.2	185.3	31.9	87.3	130.0	108.0	60.5	18.3	44.0	89.3	32.6	55.4	45.4	81.7	55.2	132.9	32.7	107.8	18.0	40.1	41.0	62.8	42.9	73.1	98.0	139.7	27.3	41.8	67.1	120.3	40.1	144.3	87.4	131.2	227.9	93.3	65.1	109.9	55.7	31.2	53.9	47.5	49.9	79.8	40.5	193.9	123.4	79.9	81.3	100.2	99.3	99.4	79.3	87.3	73.4	124.1	78.5	86.6	45.3	79.6	95.9	89.3	62.1	33.7											583.6	431.9	2723.9	906.1	795.2	0.0	21708.1	2619.1	1640.9	1064.6	1097.4	0.0	0.0	240.4	680.7	99.3	666.5	2590.2	4134.9	811.9	0.0	364.3	748.8	814.8	6052.2	0.0	0.0	752.3	2617.9	3186.6	403.9	979.2	872.2	577.0	1484.2	1582.7	0.0	1038.2	1813.1	797.6	2081.7	0.0	685.6	570.5	650.3	492.1	851.0	0.0	1584.2	1461.9	1233.6
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 395.3;skeletal muscle: 593.2"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 10763.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 524.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favorable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0.0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48.0	0.0	3.5	10.3		28.0	0.3		48.1	0.0	593.2	176.3	63.8	0.0	24.8	19.9	53.2	22.7			17.5		0.0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	99.5	80.8	71.5	90.8	12.0	1.1	51.3	134.7	0.2	0.4	0.4	109.8	101.1	214.8	91.6	3.6	13.5	149.0	0.7	2.4	0.7	126.9	62.0	128.7	524.8	313.8	0.9	81.4	121.6	2.0	3.3	3.3	2.7	68.1	0.7	45.0	55.3	84.4	2.9	212.8	25.0	112.4	15.5	57.2	39.8	60.9	45.7	92.3	1.9	293.8	29.5	47.4	70.1	123.5	55.6	118.8	95.7	158.8	273.9	79.6	67.2	112.6	53.9	28.9	77.1	51.5	54.0	83.1	46.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7											77.4	48.1	340.3	38.0	14.9	0.0	10763.4	298.1	156.6	138.8	122.1	0.0	0.0	14.9	22.5	5.1	82.2	98.6	584.0	30.5	0.0	11.3	44.8	92.7	656.7	0.0	0.0	29.0	406.4	492.6	24.4	57.8	31.8	32.1	42.3	60.4	0.0	23.3	63.7	42.5	111.6	0.0	58.2	27.7	25.6	53.0	17.9	0.0	156.7	77.0	76.6
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	33.6	36.4	26.0	27.7	31.4	19.9	32.6	26.6	24.3	18.7	23.4	20.3	28.2	27.5	41.1	27.8	40.0	32.5	36.5	25.6	21.5	37.9	50.4	28.5	66.4	45.5	24.4	43.5	31.7	32.4	34.8	19.9	15.5	30.6	23.2	28.1	15.5	42.7	25.7	59.6	30.9	41.2	38.4	87.9	65.0	31.3	24.8	82.5	56.4	48.0	19.0	25.1	54.7	67.9	36.5	36.6	17.2	51.3	29.9	16.0	16.2	33.2	51.9	39.4	48.8	35.9	29.0	51.7	19.7	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1	148.9	173.3	221.0	195.7	189.9	139.0	3052.5	636.9	330.6	205.9	533.9	74.6	331.6	1856.9	408.0	28.1	249.5	1244.9	256.9	444.8	351.6	251.4	215.4	204.5	881.4	567.3	77.9	441.2	254.8	408.9	27.3	272.7	346.6	541.6	587.1	745.3	168.3	446.0	706.9	268.0	1089.7	161.0	213.4	269.6	46.1	78.8	217.9	318.3	243.7	663.1	282.7
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025402	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		12000	Mitochondria		"CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756"	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	19.0	37.5	19.7	18.2	30.4	20.3	19.5	26.2	31.5	14.5	31.0	24.5	18.6	30.4	14.8	18.4	28.5	18.8	17.1	66.0	28.6	18.7	36.3	40.6	13.1	13.8	21.4	27.7	19.8	23.5	25.1	15.5	15.9	33.4	13.7	34.7	16.2	20.6	26.7	67.0	26.1	24.3	18.6	27.0	13.8	24.9	15.4	19.8	13.2	16.9	34.1	20.2	19.3	17.7	24.6	35.7	11.0	27.7	21.2	24.6	24.5	16.9	16.6	12.4	20.8	15.0	25.0	20.3	14.4	18.6	20.8	20.9	16.6	21.2	12.6	6.7	16.0	15.5	22.8	27.9	25.8	26.7	16.7	18.5	16.5	15.7	35.5	22.6	22.5	13.4	24.2	21.1	16.6	22.7	18.1	26.3	20.4	25.0	8.9	22.2	25.9	21.3	23.2	14.6	26.3	18.1	21.8	27.6	22.0	29.5	33.3	19.6	12.9	14.2	32.2	22.5	9.4	29.9	22.9	16.4	14.8	15.1	18.8	16.0	15.3	6.8	20.1	16.1	20.6	17.7	6.3	26.1	11.0	18.9	27.7	24.6	24.6	19.1	20.5	35.7	18.3	19.0	19.0	5.8	21.2	23.4	12.7	22.0	24.5	19.7	30.4	26.2	31.5	28.6	18.7	21.4	27.7	33.4	19.8	71.5	71.5	70.9	81.5	93.2	72.1	304.5	79.0	77.6	80.8	73.3	58.9	175.7	263.6	95.5	40.3	66.1	150.4	0.0	68.2	97.5	68.1	53.9	64.6	119.2	111.3	47.7	89.3	62.6	83.6	48.6	46.3	74.1	106.3	115.4	134.7	70.1	74.8	106.6	46.3	181.4	103.3	64.7	75.1	53.2	69.0	104.0	182.4	62.3	201.1	84.3
NDUFA11	B14.7	ENSG00000174886	"NADH:ubiquinone oxidoreductase subunit A11"	Q86Y39	19	5891276-5904006	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA072209			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA072209: AB_2686495"	"unprognostic (2.24e-1)"	"prognostic favorable (4.54e-5)"	"unprognostic (8.20e-3)"	"prognostic favorable (3.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.16e-3)"	32.3	70.8	50.2	40.9	41.3	43.4	49.3	29.9	75.2	35.3	45.1	25.8	41.2	41.6	35.9	36.9	53.1	38.4	41.4	149.3	41.9	45.8	44.1	59.8	37.9	51.9	48.3	45.8	38.4	70.9	13.5	33.8	32.5	35.9	35.1	19.6	35.9	76.3	41.1	106.0	32.4	39.5	45.2	40.2	31.5	38.8	21.2	27.0	37.3	37.8	72.1	30.5	38.3	37.2	63.3	90.2	54.3	87.4	44.8	73.7	121.4	49.2	38.1	28.4	46.2	23.3	37.9	31.8	34.1	39.4	62.5	57.8	45.5	26.3	48.7	53.8	32.5	26.8	32.6	19.6	39.7	15.1	42.0	73.5	20.0	36.6	72.7	61.0	29.7	29.8	51.8	36.1	35.4	16.8	24.1	40.7	44.8	42.2	54.3	31.4	37.5	77.1	53.0	43.0	39.3	95.9	53.5	35.5	69.7	38.6	33.0	41.1	43.7	26.5	43.6	60.0	12.7	33.5	63.4	36.4	34.9	33.5	69.3	55.6	82.6	71.6	63.0	58.8	71.4	44.7	54.3	87.4	47.7	53.5	68.0	54.8	63.3	59.6	54.0	74.9	54.6	56.7	49.5	39.2	44.8	57.7	90.2	73.7	121.4	50.2	41.3	29.9	75.2	41.9	45.8	48.3	45.8	35.9	27.0	134.0	182.8	195.8	195.3	182.6	52.9	357.1	252.3	159.3	142.1	277.4	23.6	487.2	712.9	246.9	126.8	162.6	455.6	140.2	261.1	500.5	250.4	204.0	208.9	654.2	369.3	47.7	337.5	259.7	354.1	271.6	180.4	216.7	271.7	380.5	351.7	119.5	275.3	350.7	157.3	766.8	60.4	116.4	219.2	83.0	80.8	212.9	496.2	182.7	391.9	191.2
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003770	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Group enriched"	"Detected in all"	5	"Cardiomyocytes: 2083.1;Distal tubular cells: 525.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	24.0	24.8	36.0	17.9	36.8	19.7	19.7	27.2	36.5	17.9	35.5	12.5	20.0	27.4	17.0	21.9	23.3	19.4	14.4	82.8	31.2	32.0	33.2	34.6	18.1	20.1	37.0	29.9	17.0	18.4	22.3	22.4	21.1	31.3	19.1	35.7	13.1	18.7	20.7	129.0	17.4	26.7	24.0	24.2	23.9	20.9	14.2	23.5	21.0	27.9	40.0	28.1	21.9	21.4	60.8	78.4	69.7	67.9	59.1	93.8	100.6	41.6	45.3	37.9	26.9	31.1	29.0	28.2	19.9	29.3	43.5	39.5	55.9	21.5	47.9	11.8	30.4	24.1	31.5	38.9	45.9	49.4	41.3	46.7	40.1	37.8	56.3	32.0	56.8	49.0	31.1	58.0	36.4	44.7	45.5	35.6	41.7	37.4	22.3	42.1	60.4	39.3	87.8	28.7	51.2	78.9	30.1	32.8	54.6	42.6	62.6	36.1	21.9	33.7	49.2	25.8	34.2	48.6	37.4	40.6	23.1	23.5	33.5	33.8	36.4	54.0	73.1	13.9	47.6	35.2	69.7	59.5	29.8	52.1	67.9	48.2	60.8	71.6	62.5	78.4	50.7	93.8	68.6	8.6	59.1	63.3	48.0	74.8	100.6	36.0	36.8	27.2	36.5	31.2	32.0	37.0	29.9	31.3	23.5	68.5	58.6	79.6	121.2	96.5	65.8	2083.1	160.5	77.6	45.5	102.9	60.9	215.5	525.6	141.2	192.8	157.8	177.2	46.7	143.2	214.5	94.4	120.9	56.6	123.1	168.7	35.0	81.9	98.8	95.5	70.6	90.3	125.9	151.8	218.2	146.8	79.4	169.8	188.7	125.5	242.6	113.4	103.5	149.9	130.8	119.2	111.7	175.3	96.5	189.4	182.6
NDUFA13	"B16.6, CDA016, CGI-39, GRIM-19, GRIM19"	ENSG00000186010	"NADH:ubiquinone oxidoreductase subunit A13"	Q9P0J0	19	19515736-19529054	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.3;testis: 140.2"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 2344.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041213	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041213: AB_10794988"	"unprognostic (2.87e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.15e-2)"	17.9	16.9	20.0	11.7	23.9	15.4	14.4	20.7	25.2	11.0	19.2	8.7	16.5	16.5	9.7	19.6	12.2	11.7	12.9	68.0	16.4	13.9	18.9	20.8	8.4	11.9	19.9	22.3	10.6	17.8	10.6	12.1	12.1	20.0	12.9	11.9	9.8	15.2	15.5	79.7	9.5	14.9	12.1	13.4	10.1	15.0	140.2	16.2	7.6	11.3	28.1	8.4	9.6	10.2	73.7	74.9	61.4	76.8	44.8	72.7	116.3	33.1	24.5	45.3	45.0	46.2	37.5	42.5	39.5	43.8	44.6	43.5	39.7	49.8	44.1	93.0	47.6	27.8	27.0	32.0	42.9	18.4	26.9	72.4	33.7	39.1	48.6	41.3	63.3	47.6	50.3	39.0	31.2	36.0	31.5	32.0	51.6	37.2	63.2	35.4	65.9	75.1	62.9	46.1	85.3	68.2	43.1	29.4	67.4	65.0	47.6	43.0	54.4	40.2	47.4	39.3	26.4	29.3	87.2	33.3	43.7	14.8	50.9	49.0	45.0	35.4	47.5	38.5	49.2	31.9	61.4	76.8	57.8	51.2	72.9	45.5	73.7	58.9	56.0	74.9	60.5	56.9	51.1	26.9	44.8	60.8	61.2	72.7	116.3	20.0	23.9	20.7	25.2	16.4	13.9	19.9	22.3	20.0	16.2	122.1	153.3	217.5	53.6	114.6	57.3	436.5	216.6	210.1	204.8	237.3	23.6	341.6	517.3	485.5	369.3	147.4	952.4	140.2	502.5	299.6	215.0	71.6	253.9	389.3	292.2	39.7	534.5	181.7	314.3	2344.2	142.1	234.7	249.7	531.2	516.2	105.2	438.1	641.8	121.3	667.2	59.7	90.5	183.3	59.7	92.9	111.0	416.8	195.8	508.5	65.7
NDUFA2	B8	ENSG00000131495	"NADH:ubiquinone oxidoreductase subunit A2"	O43678	5	140638740-140647785	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035933	Approved					NA	NA		12000			"HPA035933: AB_10669661"	"unprognostic (4.48e-1)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.30e-3)"	25.6	41.5	37.1	19.2	35.1	31.1	23.1	20.8	31.0	18.0	29.1	13.1	33.9	34.2	12.8	28.1	22.8	18.2	29.8	55.8	30.3	30.5	41.4	44.8	19.7	23.5	35.6	22.1	17.6	40.8	9.0	23.1	21.2	24.1	20.2	21.4	18.1	39.6	37.4	90.9	13.5	30.9	18.9	25.5	22.1	24.2	21.4	21.7	22.0	26.9	46.7	17.2	17.5	15.7	47.0	64.1	66.6	66.9	31.3	48.7	63.1	25.1	36.6	18.0	37.1	21.0	15.6	23.7	15.0	12.6	18.3	22.6	56.1	28.5	23.1	36.7	12.0	23.9	19.7	16.3	27.9	10.7	23.1	43.1	15.0	34.9	42.9	12.8	26.4	19.6	18.7	20.8	12.1	8.7	16.0	18.8	24.3	15.5	37.2	16.7	35.5	35.7	52.8	19.0	28.1	36.7	27.9	22.2	39.9	29.9	26.1	23.1	20.4	20.8	53.3	40.0	16.3	50.0	40.8	13.7	21.8	16.9	19.0	23.4	41.9	60.6	34.2	25.8	29.4	12.8	33.8	66.9	66.6	33.3	56.8	34.2	47.0	36.7	36.8	55.9	40.0	34.0	35.5	60.0	31.3	44.8	64.1	48.7	63.1	37.1	35.1	20.8	31.0	30.3	30.5	35.6	22.1	24.1	21.7	101.3	102.6	131.8	103.7	86.8	78.7	263.8	211.5	141.8	108.1	232.1	35.3	258.0	691.4	157.7	418.1	98.7	492.0	186.9	192.0	193.4	113.2	137.5	90.1	429.3	254.8	50.9	185.7	161.4	214.5	291.3	152.8	157.0	180.5	259.7	266.5	118.0	177.0	343.7	144.2	695.9	79.5	116.4	135.9	168.6	261.8	102.3	186.0	119.4	305.6	136.6
NDUFA3	B9	ENSG00000170906	"NADH:ubiquinone oxidoreductase subunit A3"	O95167	19	54102728-54109257	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1041.5;Late spermatids: 1291.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 38.9"	"Low region specificity"	"Detected in all"							HPA046976	Supported					NA	NA					"HPA046976: AB_10960994"	"unprognostic (3.04e-2)"	"unprognostic (4.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (9.91e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	"prognostic favorable (4.80e-4)"	17.7	20.8	47.4	15.4	50.9	21.8	22.0	17.3	36.5	12.8	22.6	13.7	21.5	31.8	11.7	25.1	15.8	17.1	20.0	66.1	40.9	33.1	29.7	37.2	20.8	26.9	43.3	31.1	12.9	34.0	22.2	25.5	12.3	29.5	15.9	25.8	13.9	27.0	24.7	95.7	42.4	27.6	15.7	26.8	14.7	23.7	32.6	19.6	16.1	19.5	34.7	16.6	16.3	15.1	20.9	27.3	21.7	16.7	17.1	16.4	18.8	5.4	4.7	4.7	6.4	6.2	5.7	3.7	4.6	5.0	3.7	4.2	5.9	4.0	4.3	3.1	4.1	3.6	3.4	3.7	8.9	1.7	6.5	19.6	4.8	6.3	6.6	4.4	5.3	2.0	3.7	8.8	3.2	4.3	2.5	6.7	4.2	2.6	3.1	3.7	17.4	4.9	6.2	3.9	38.9	9.0	2.2	2.5	9.0	2.7	13.6	7.8	4.1	4.3	10.3	2.5	5.8	12.0	5.2	5.9	4.9	2.4	2.1	7.5	4.7	3.5	2.5	5.4	5.0	2.3	17.2	16.3	21.7	15.0	16.7	15.0	20.9	15.5	15.6	15.8	19.8	16.3	16.4	15.9	17.1	13.7	27.3	15.4	18.8	47.4	50.9	17.3	36.5	40.9	33.1	43.3	31.1	29.5	19.6	89.3	115.3	159.2	44.9	35.3	34.7	1041.5	244.5	190.1	113.7	373.4	9.8	147.2	691.4	171.8	409.1	107.4	555.4	163.5	167.0	149.5	119.0	58.2	112.2	459.8	264.7	22.3	288.8	206.2	255.7	1291.0	151.0	163.3	207.5	272.3	310.4	63.8	191.8	343.7	133.0	664.3	46.3	84.1	82.1	132.9	71.5	54.6	124.1	142.2	317.6	56.7
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055323, HPA078265"	Approved		Approved	Mitochondria		NA	NA		18000	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	11.4	19.7	33.6	38.7	19.1	18.0	15.5	14.5	13.8	13.7	12.1	24.7	31.5	22.4	13.9	20.9	37.5	20.3	22.3	17.3	15.0	11.0	16.3	18.7	23.2	23.0	16.7	25.8	18.5	19.3	17.4	16.7	14.8	26.1	19.0	20.2	27.8	30.5	28.5	22.1	11.5	22.7	36.8	78.1	40.0	15.6	24.0	25.1	34.7	24.9	21.1	21.9	23.1	66.5	13.1	49.0	42.0	31.7	16.6	16.3	22.6	23.4	24.0	18.5	23.6	25.7	22.6	27.9	50.7	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2	455.6	386.9	389.1	472.6	361.6	472.0	3966.4	996.2	704.0	533.5	903.7	251.3	756.7	3355.6	748.9	115.7	549.6	532.5	186.9	833.3	599.3	543.2	716.7	552.0	1498.2	844.7	149.4	201.3	748.3	552.8	81.7	457.0	587.9	868.9	625.8	610.1	384.0	636.5	584.4	737.2	2069.7	472.4	329.8	932.8	105.9	274.8	422.2	550.9	350.3	618.2	678.3
NDUFA5	"B13, CI-13kB, CI-13KD-B, NUFM, UQOR13"	ENSG00000128609	"NADH:ubiquinone oxidoreductase subunit A5"	Q16718	7	123536997-123558255	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 621.7;Distal tubular cells: 906.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043175	Supported					NA	NA		69000			"HPA043175: AB_10793992"	"prognostic favorable (8.47e-5)"	"unprognostic (4.00e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.20e-2)"	"prognostic favorable (3.99e-9)"	"unprognostic (3.39e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.73e-3)"	13.9	39.9	50.4	9.5	47.5	9.5	22.1	30.3	56.3	16.9	22.2	9.9	17.9	22.3	15.7	22.7	16.5	16.5	14.7	64.9	53.9	41.5	53.6	33.6	13.4	10.7	42.6	37.8	14.3	12.2	32.5	31.0	12.7	42.1	23.4	23.7	13.4	22.3	20.6	67.2	9.1	20.7	18.4	29.3	10.6	21.6	13.2	16.0	9.7	43.1	30.4	12.7	16.8	10.8	22.9	18.2	21.3	22.3	24.2	27.0	26.4	12.1	7.0	15.8	20.1	15.7	16.5	8.2	10.4	15.2	11.8	15.8	7.1	16.5	22.2	10.9	12.8	17.9	14.3	18.4	16.3	18.4	16.1	12.6	12.5	14.0	14.6	15.8	28.8	14.2	13.5	17.0	10.1	11.0	18.1	17.1	15.0	43.6	27.8	21.0	7.2	28.0	40.0	24.1	30.0	17.8	15.5	16.7	36.2	31.3	11.2	36.1	20.4	15.0	76.3	19.4	22.2	17.6	24.5	9.9	16.0	6.2	69.5	17.5	23.5	18.0	22.8	32.6	24.3	20.4	21.3	11.7	12.8	18.7	20.0	27.0	22.9	23.8	20.7	15.2	17.7	26.0	26.2	4.0	24.2	22.3	18.2	23.7	26.4	50.4	47.5	30.3	56.3	53.9	41.5	42.6	37.8	42.1	16.0	95.3	84.9	88.1	116.9	99.9	176.7	621.7	101.9	151.3	88.7	157.1	78.5	138.8	906.9	106.8	269.2	99.3	135.7	23.3	78.8	126.5	106.9	130.3	86.6	142.1	96.9	120.8	132.4	49.1	59.6	48.7	83.4	82.4	192.3	59.5	113.6	182.8	78.5	127.9	105.4	520.3	174.3	116.4	138.7	134.2	94.5	96.4	132.5	99.2	140.2	118.0
NDUFA6	"B14, CI-B14, LYRM6, NADHB14"	ENSG00000184983	"NADH:ubiquinone oxidoreductase subunit A6"	P56556	22	42085525-42090955	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 1434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.48e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (7.00e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.84e-2)"	11.1	18.3	18.4	11.6	18.9	16.9	17.3	16.4	17.7	7.8	21.8	8.7	15.7	11.4	10.2	12.7	20.0	8.0	13.3	68.5	14.7	15.3	30.8	39.1	11.5	13.0	18.8	15.0	8.5	17.3	35.1	13.3	22.0	16.2	15.4	30.8	13.2	16.0	15.1	55.8	11.2	25.8	13.8	11.4	11.4	18.9	8.7	9.3	14.0	15.0	34.2	12.9	19.4	10.2	22.6	34.9	26.9	28.3	19.5	25.7	34.8	7.1	0.8	1.9	7.6	15.5	11.5	4.1	0.1	0.1	0.3	0.4	7.4	13.8	0.2	0.7	11.8	1.0	8.3	0.5	0.5	1.8	0.1	0.3	0.4	3.8	25.9	0.3	12.8	12.6	6.9	8.3	9.9	15.4	0.7	6.3	0.8	11.4	13.8	0.6	13.9	7.2	1.5	6.8	20.8	21.7	11.6	7.1	0.1	0.6	2.7	0.4	4.9	13.7	9.4	23.4	2.7	15.8	0.2	0.0	1.0	17.8	7.7	12.1	8.2	11.1	1.6	5.5	14.7	15.8	19.3	27.2	26.9	19.5	26.6	19.6	22.6	25.7	17.3	34.9	20.3	20.5	22.6	9.4	19.5	28.3	23.0	25.6	34.8	18.4	18.9	16.4	17.7	14.7	15.3	18.8	15.0	16.2	9.3	56.6	80.3	104.2	178.3	165.0	55.0	1434.3	198.7	101.7	64.8	171.0	43.2	382.8	809.1	225.5	144.1	130.4	388.3	93.5	220.7	352.4	189.5	145.7	102.7	481.4	312.1	33.4	164.0	92.1	111.7	34.7	93.5	166.9	273.3	270.5	197.2	82.8	223.5	252.6	104.0	407.8	67.6	103.5	197.5	102.4	159.0	162.6	639.0	103.6	249.2	201.5
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159819	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 105.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 528.1;Distal tubular cells: 520.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		14000	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	15.4	20.0	35.9	9.5	40.5	7.3	16.5	18.8	36.8	14.2	23.4	12.4	19.6	19.4	12.6	26.9	17.0	18.9	16.9	105.4	32.3	27.5	29.0	23.6	10.9	11.2	31.3	30.3	11.3	16.8	21.8	15.3	14.1	22.4	17.9	26.6	14.6	25.1	19.7	68.3	11.1	17.4	22.0	19.1	10.9	18.0	25.1	16.8	10.0	18.5	30.9	15.8	15.6	15.3	29.7	39.7	22.2	34.3	25.5	30.8	24.3	17.9	33.3	22.1	29.1	23.9	22.0	27.4	21.0	24.9	28.8	24.3	42.2	17.9	26.3	20.8	24.5	52.6	45.3	41.8	45.3	28.4	25.8	28.9	20.7	55.9	36.4	25.8	36.5	21.4	24.0	44.3	28.8	18.5	26.5	41.2	29.5	31.5	19.8	32.8	45.7	22.6	23.8	20.2	81.0	64.2	18.2	34.9	38.3	41.4	25.0	38.3	15.1	32.9	39.1	26.0	23.6	41.4	17.6	26.7	16.0	16.1	30.0	23.4	22.4	36.1	26.0	33.3	23.7	26.4	5.1	29.4	22.2	29.1	34.3	27.8	29.7	27.0	28.4	38.1	29.3	29.0	30.5	4.8	25.5	28.8	39.7	30.8	24.3	35.9	40.5	18.8	36.8	32.3	27.5	31.3	30.3	22.4	16.8	26.8	30.2	50.6	59.9	42.8	43.3	528.1	56.0	69.6	48.9	78.5	27.5	106.7	520.6	91.1	282.6	89.5	102.7	46.7	88.4	95.7	43.5	75.0	19.7	93.1	108.4	42.9	74.3	58.3	41.0	68.2	52.3	46.0	89.4	88.4	92.7	52.1	87.8	87.7	70.7	161.2	38.8	25.8	56.7	227.6	125.0	49.7	105.8	45.0	118.7	71.0
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 461.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.9	19.8	9.8	13.0	7.2	7.2	28.3	8.4	8.5	16.3	12.4	42.9	22.1	12.4	4.5	9.1	18.4	18.5	14.1	12.4	10.6	24.0	24.8	12.1	21.1	32.4	15.8	17.6	13.1	9.2	12.1	11.1	15.1	10.1	12.2	17.8	8.4	23.5	12.0	21.3	17.6	20.3	25.2	20.7	16.5	24.9	14.4	12.9	22.4	25.1	7.1	8.0	10.6	28.5	14.7	22.2	5.9	16.9	8.5	12.4	25.2	11.3	19.4	4.6	5.4	20.5	13.0	11.0	13.6	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3	26.8	28.0	46.2	52.9	43.0	46.1	165.0	50.9	41.5	36.4	61.1	55.0	100.9	140.9	108.0	102.8	42.7	83.0	23.3	114.3	98.5	39.0	37.2	56.6	65.2	101.8	31.8	45.5	34.4	33.6	461.4	26.2	46.0	52.3	57.7	92.6	40.4	94.0	94.8	34.6	133.6	48.3	19.4	42.6	28.8	28.1	41.3	83.5	45.7	120.3	64.7
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 1253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	28.2	20.9	26.2	23.3	18.7	20.2	36.4	21.8	16.2	22.0	18.1	18.1	23.0	46.8	35.8	15.7	27.4	23.4	45.5	25.9	17.5	26.5	52.6	25.1	37.5	88.9	19.6	46.6	20.9	18.8	36.0	16.2	17.5	20.7	27.9	42.3	52.6	23.8	23.8	42.8	36.0	70.9	68.0	42.2	48.6	49.6	29.5	63.7	20.2	25.4	36.0	28.1	24.4	44.7	40.7	30.1	36.1	39.0	21.9	20.2	21.2	19.5	29.9	30.4	44.2	52.5	22.6	37.7	22.8	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5	92.3	83.8	96.1	105.6	108.4	80.0	1253.7	109.5	175.3	81.9	106.4	43.2	246.2	600.2	140.5	81.4	113.0	204.9	70.0	182.7	251.9	115.6	117.8	83.1	281.9	233.1	49.3	194.3	96.3	110.6	24.0	89.8	100.2	148.5	155.9	210.6	118.9	192.1	168.4	114.2	541.1	90.3	90.5	123.0	114.6	115.3	124.3	187.8	90.6	317.0	150.7
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 161.6"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 2033.2;Hepatocytes: 1436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	38.3	48.3	47.8	22.4	43.1	30.2	22.1	30.9	53.6	12.4	39.7	13.4	28.1	36.4	14.8	39.2	23.2	15.9	20.0	142.2	38.4	35.7	51.2	64.6	28.1	24.9	40.6	36.0	16.5	48.5	9.9	30.6	13.2	41.8	19.3	26.9	22.9	54.1	35.9	161.6	12.6	32.9	25.9	31.3	19.3	29.4	10.0	26.4	11.9	21.6	48.9	21.3	17.1	16.3	61.7	98.6	116.1	93.9	45.1	70.1	95.0	27.1	55.1	44.7	28.8	29.3	21.9	20.5	33.5	18.9	19.9	18.4	33.2	46.3	24.5	31.2	18.7	29.1	34.0	25.6	27.2	18.0	38.6	58.5	47.5	86.5	39.5	23.3	37.5	27.2	27.0	16.5	20.8	18.4	47.1	17.7	47.1	25.8	50.5	27.2	102.8	37.0	33.6	22.6	103.1	67.5	33.1	42.5	36.4	49.6	67.3	29.9	21.7	65.6	40.0	42.6	39.3	59.8	58.6	39.5	12.7	24.1	25.3	22.3	40.0	62.3	54.5	38.2	27.8	26.2	58.1	93.9	67.8	43.7	63.5	50.2	61.7	64.7	49.8	82.6	52.0	65.4	60.4	116.1	45.1	58.1	98.6	70.1	95.0	47.8	43.1	30.9	53.6	38.4	35.7	40.6	36.0	41.8	26.4	154.9	246.4	237.3	88.1	114.4	72.8	2033.2	565.6	282.4	178.6	369.9	37.3	225.4	988.2	197.4	98.7	145.0	655.0	280.4	371.9	86.0	164.5	117.3	207.1	1436.2	359.0	52.4	305.2	426.6	707.7	29.0	243.1	282.3	315.5	296.6	433.5	108.9	268.5	512.0	226.7	864.5	130.9	219.9	185.4	133.6	144.5	153.9	172.1	204.2	467.2	90.1
NDUFB10	PDSW	ENSG00000140990	"NADH:ubiquinone oxidoreductase subunit B10"	O96000	16	1959508-1961975	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 280.4"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073189	Supported					NA	NA					"HPA073189: AB_2686579"	"unprognostic (3.56e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.43e-6)"	"unprognostic (1.24e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.43e-1)"	"unprognostic (8.76e-2)"	21.6	20.3	29.0	18.3	30.9	15.6	23.5	21.0	32.2	18.2	31.3	17.0	22.2	32.3	18.8	22.9	22.1	18.9	22.0	97.1	26.9	20.1	28.8	33.9	13.0	22.3	27.7	28.7	15.4	29.8	26.3	13.3	15.1	20.1	18.9	28.2	17.9	32.0	24.2	280.4	16.8	27.8	27.5	18.9	15.7	25.2	19.2	15.6	16.6	20.0	73.7	17.3	20.1	17.7	64.6	84.7	66.6	75.5	51.8	84.8	80.2	17.4	51.4	24.7	29.6	24.9	23.7	25.6	21.8	26.4	25.3	17.4	37.8	23.7	35.6	37.3	27.9	13.5	37.3	27.2	33.3	19.1	32.6	101.2	27.5	40.7	42.8	32.0	44.3	26.6	26.6	30.2	24.4	27.4	27.3	29.3	31.9	25.6	35.0	32.1	72.9	52.2	46.2	31.7	46.6	58.6	61.7	26.4	76.3	36.8	18.1	56.1	36.0	41.0	66.7	28.7	15.2	40.5	30.1	25.1	23.6	22.3	33.5	23.7	58.0	44.5	46.6	16.6	22.2	24.7	54.8	75.5	66.6	57.7	63.2	55.8	64.6	71.2	72.1	79.0	58.0	56.9	59.5	41.3	51.8	53.2	84.7	84.8	80.2	29.0	30.9	21.0	32.2	26.9	20.1	27.7	28.7	20.1	15.6	107.2	71.6	131.7	132.1	151.5	82.2	1107.2	300.7	160.6	76.2	207.6	17.7	313.5	832.3	248.3	262.3	175.5	627.2	163.5	362.2	264.7	185.2	120.1	110.6	343.0	279.7	74.7	195.8	149.8	199.0	686.6	146.4	164.2	263.2	256.9	319.4	135.9	259.6	427.8	146.7	623.8	82.2	187.5	259.7	198.1	121.6	159.6	167.3	149.5	388.8	110.0
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145504	"Disease related genes, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Cardiomyopathy, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	16.9	33.4	26.1	21.2	24.8	25.2	29.2	18.9	29.7	17.6	23.3	10.5	24.7	24.2	14.3	25.1	23.3	18.8	24.0	64.4	22.4	20.6	24.4	48.8	18.1	36.5	22.5	22.0	14.9	50.9	15.6	24.5	14.2	24.4	18.1	21.2	13.0	37.0	30.2	164.0	17.3	22.8	16.0	18.3	19.2	22.8	9.7	12.3	30.4	38.5	53.6	21.2	14.3	20.5	58.9	69.0	22.2	44.7	27.7	54.6	59.5	19.9	29.7	23.5	27.1	20.3	17.5	25.0	14.5	16.9	23.8	23.1	31.6	24.5	24.6	12.6	15.8	25.1	25.6	26.4	15.4	16.0	23.7	70.6	14.1	40.6	26.1	20.4	23.6	21.7	19.1	14.1	20.6	13.7	15.3	17.7	32.1	16.8	32.4	13.3	45.1	27.8	65.3	36.7	23.8	54.6	30.3	23.2	55.8	24.1	21.3	43.3	32.0	27.6	31.8	22.0	31.3	45.6	30.9	13.5	16.7	22.8	31.0	17.0	32.0	27.9	27.5	18.2	14.8	22.2	22.2	44.7	19.8	34.0	32.0	42.2	58.9	48.4	39.0	52.8	52.8	54.6	43.6	9.5	27.7	23.7	69.0	51.0	59.5	26.1	24.8	18.9	29.7	22.4	20.6	22.5	22.0	24.4	12.3	98.3	106.3	255.4	204.6	230.6	88.2	209.9	272.6	84.3	121.7	275.7	35.3	385.7	494.0	274.0	3.3	148.1	318.7	303.7	319.8	368.1	203.9	216.1	191.4	557.4	340.7	52.4	317.3	186.6	292.7	7.4	168.2	251.5	251.4	301.2	382.3	151.0	288.4	321.1	165.9	606.1	75.5	161.7	184.4	17.2	37.7	253.9	377.1	200.3	398.2	277.3
NDUFB2	"AGGG, CI-AGGG"	ENSG00000090266	"NADH:ubiquinone oxidoreductase subunit B2"	O95178	7	140690777-140722790	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 153.5"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051377	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA051377: AB_2681460"	"unprognostic (1.17e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (7.60e-7)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.55e-1)"	25.1	31.2	45.1	19.9	52.5	20.2	27.3	29.1	43.3	21.5	39.0	26.0	25.1	28.3	20.1	29.5	27.7	22.0	25.7	105.5	37.0	36.0	46.6	41.2	18.4	23.8	46.0	35.6	14.5	47.0	26.5	23.9	17.7	33.3	20.7	30.8	28.1	37.6	27.4	127.2	17.2	28.1	38.1	37.7	19.7	26.9	14.3	25.2	15.6	57.6	48.1	21.1	25.5	17.5	94.7	116.5	55.2	108.5	75.9	87.8	153.5	41.1	67.0	24.0	52.4	38.6	39.2	34.9	29.9	26.2	31.0	29.6	51.7	41.1	31.3	44.8	36.2	58.7	20.4	21.4	42.1	24.7	52.2	73.6	22.9	57.3	58.1	30.6	35.3	30.9	43.6	36.5	29.4	18.1	26.6	46.1	44.5	38.7	37.9	42.9	122.0	55.3	91.1	55.6	84.7	76.6	31.9	23.4	72.2	62.1	81.8	48.9	48.3	41.0	67.2	35.9	28.6	29.2	40.5	38.4	41.0	24.1	48.4	51.5	36.2	67.2	54.9	62.4	56.8	51.3	55.2	108.5	48.1	83.5	107.8	71.3	94.7	82.1	81.4	116.5	72.9	87.8	87.7	9.0	75.9	97.1	92.8	73.9	153.5	45.1	52.5	29.1	43.3	37.0	36.0	46.0	35.6	33.3	25.2	175.7	232.0	217.4	229.1	201.1	175.8	3102.3	435.7	235.5	197.9	638.6	92.3	489.8	1692.7	343.0	795.3	237.8	727.9	70.0	273.3	377.8	291.6	360.2	272.6	944.1	632.0	131.9	411.8	215.5	261.6	154.7	206.2	385.8	411.7	381.5	493.4	197.7	268.8	531.3	229.1	1640.6	200.8	194.1	278.2	77.7	190.5	245.3	430.7	214.4	506.9	369.0
NDUFB3	B12	ENSG00000119013	"NADH:ubiquinone oxidoreductase subunit B3"	O43676	2	201071433-201085750	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.9"	"Cell type enhanced"	"Detected in all"	10	"Cardiomyocytes: 1805.8;Distal tubular cells: 901.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034596	Enhanced					NA	NA					"HPA034596: AB_10602712"	"unprognostic (5.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.81e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.27e-2)"	16.9	19.9	23.4	13.9	23.6	10.1	14.7	13.5	33.3	10.4	27.1	8.2	16.8	23.8	8.4	18.9	21.1	8.6	13.0	57.5	24.2	19.9	35.2	25.8	10.4	12.6	25.6	29.7	6.8	13.0	15.3	13.2	10.9	20.8	11.7	23.8	8.8	21.8	11.7	113.9	8.6	21.2	10.8	19.2	13.4	17.5	17.2	17.8	10.8	11.6	39.1	16.9	9.4	12.0	40.5	55.8	66.2	52.9	36.4	47.3	27.2	25.1	20.6	31.1	17.6	26.6	22.9	26.7	29.4	18.6	21.7	23.8	46.1	31.2	18.1	36.5	24.1	34.8	23.9	25.4	35.8	33.2	37.3	59.5	42.1	49.9	54.3	17.2	60.6	24.7	22.3	27.1	25.4	15.1	25.9	27.9	33.3	38.3	35.8	34.3	29.3	43.4	67.3	20.7	48.1	68.3	31.8	25.9	55.9	46.2	38.4	31.1	22.7	22.5	23.7	36.8	47.5	22.1	54.0	27.9	20.8	27.8	22.0	31.6	27.3	54.2	61.4	37.7	35.5	24.1	43.5	37.7	40.0	32.7	51.7	36.3	40.5	38.5	37.8	45.8	31.4	33.8	41.2	66.2	36.4	52.9	55.8	47.3	27.2	23.4	23.6	13.5	33.3	24.2	19.9	25.6	29.7	20.8	17.8	74.5	43.1	110.7	86.1	69.4	45.6	1805.8	155.4	131.2	79.6	177.9	11.8	229.3	901.9	200.3	116.7	76.5	387.2	23.3	176.3	165.0	71.9	72.2	76.2	207.9	250.1	30.2	140.6	86.5	115.2	32.2	88.3	118.4	160.3	347.2	205.2	105.4	170.7	284.0	95.5	609.5	64.6	90.5	95.2	200.4	91.8	80.4	131.8	87.3	261.2	108.6
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.3	37.5	44.9	44.9	28.3	33.8	36.5	28.9	38.4	37.6	41.6	36.4	39.5	26.1	58.7	32.3	47.2	49.8	34.6	36.8	28.4	40.0	39.8	40.3	39.4	36.6	17.2	35.4	47.8	30.5	49.1	18.3	24.1	45.6	46.9	49.7	23.8	40.2	40.3	40.3	70.0	51.3	35.7	84.6	102.8	40.6	25.6	57.4	60.9	32.1	50.6	51.8	33.9	38.0	61.5	31.3	64.0	56.5	36.0	33.3	43.9	14.1	40.2	49.6	44.7	78.9	52.6	49.9	45.1	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6	151.8	116.9	147.4	227.4	197.5	114.3	1416.5	333.7	208.8	175.1	303.6	55.0	310.4	1039.5	474.7	797.6	248.2	436.8	93.5	541.7	349.0	180.0	247.2	169.9	411.5	288.6	79.4	286.7	153.4	221.7	73.1	254.9	235.4	411.7	399.5	378.0	175.1	503.3	436.8	260.6	758.9	123.5	252.2	270.2	329.1	90.3	219.8	294.7	162.0	391.3	307.0
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.4	6.6	16.4	19.9	21.7	29.2	22.2	14.9	18.8	21.3	21.6	19.7	17.1	20.5	45.2	12.6	36.6	26.0	17.7	19.7	21.5	42.4	14.8	22.0	12.0	16.4	19.9	26.3	17.5	26.9	25.5	12.0	20.0	22.1	24.4	20.0	18.6	29.9	22.8	16.7	15.1	20.4	23.7	45.5	26.7	16.8	19.0	63.6	38.6	18.1	11.7	19.6	9.0	50.9	35.1	15.4	77.6	42.9	15.7	14.1	13.4	19.2	35.4	39.8	41.2	30.3	22.8	28.2	20.0	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4	44.7	44.0	87.9	92.8	75.7	45.3	340.1	112.1	52.2	53.4	83.7	31.4	192.8	431.0	110.3	85.8	85.1	125.2	0.0	92.5	115.9	83.1	75.7	92.3	108.0	222.8	38.1	112.9	97.6	229.9	13.7	75.1	156.2	128.2	124.4	173.7	74.4	86.7	189.4	65.7	379.0	54.1	71.1	81.4	233.1	125.2	77.5	192.3	81.2	242.9	137.2
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 591.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	30.2	18.6	20.7	23.7	14.1	13.2	13.3	20.3	16.6	18.8	20.8	18.2	13.7	22.6	21.2	13.9	19.5	17.2	19.5	22.4	14.1	31.0	31.3	53.7	28.6	18.8	13.8	26.7	13.9	13.6	10.9	16.9	12.9	14.2	16.9	34.7	17.1	25.5	20.9	17.5	36.0	63.1	21.9	26.0	41.4	24.8	17.4	20.9	21.0	11.4	20.9	23.6	23.5	27.0	13.6	16.2	25.5	20.8	15.0	20.5	31.1	22.6	29.7	11.4	21.2	36.6	34.3	18.9	9.6	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1	116.1	94.0	77.4	80.5	83.7	39.2	514.3	107.0	155.2	108.1	102.9	5.9	175.9	452.6	143.9	591.4	96.3	138.7	93.5	145.0	113.2	93.0	79.2	86.8	170.4	141.7	17.5	62.0	71.8	59.8	88.6	84.8	89.6	151.8	111.8	116.6	72.0	133.2	118.5	84.5	440.9	40.8	103.5	124.6	143.8	114.3	84.6	87.1	65.4	146.3	88.4
NDUFB7	"B18, CI-B18, MGC2480"	ENSG00000099795	"NADH:ubiquinone oxidoreductase subunit B7"	P17568	19	14566078-14572062	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002817	Enhanced					NA	NA					"HPA002817: AB_1079462"	"unprognostic (2.80e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.25e-3)"	35.5	34.0	42.1	24.1	37.3	26.0	34.6	25.1	50.3	24.7	36.2	19.4	28.5	36.6	22.2	31.6	28.3	27.2	31.9	110.4	32.6	32.3	36.2	44.9	22.6	26.8	40.7	29.6	21.3	55.1	20.4	23.9	21.8	29.3	24.5	17.0	24.9	58.1	30.8	182.0	22.6	32.7	28.7	26.4	18.9	30.3	20.9	20.0	20.4	27.6	65.5	19.7	19.3	23.6	64.2	82.6	48.7	77.5	67.3	83.1	90.6	37.0	37.4	15.2	32.3	13.2	13.3	26.9	17.3	19.4	32.4	30.8	49.7	20.6	16.9	52.1	16.1	14.1	29.1	10.0	37.9	4.3	26.1	50.9	32.7	61.6	51.3	23.4	21.1	22.7	21.6	31.7	17.0	8.0	9.1	25.9	30.8	20.1	31.1	14.9	70.1	34.3	47.2	38.6	35.2	122.9	26.8	18.1	40.9	22.6	39.7	32.9	35.1	18.1	42.3	46.0	4.1	27.8	38.1	19.1	41.2	20.0	52.0	31.8	42.5	43.5	21.1	39.5	41.2	27.6	48.7	77.5	23.8	83.1	68.5	77.1	64.2	56.8	70.0	74.7	56.9	47.6	62.2	21.9	67.3	64.7	82.6	63.8	90.6	42.1	37.3	25.1	50.3	32.6	32.3	40.7	29.6	29.3	20.0	71.5	82.9	160.0	137.4	118.5	101.4	590.7	285.3	140.5	116.0	246.0	53.0	296.5	978.2	260.6	63.3	159.0	823.9	93.5	394.9	276.1	228.8	165.8	101.4	537.7	331.0	68.3	319.0	192.8	231.2	180.8	192.1	159.9	359.4	312.8	436.8	150.4	310.7	547.1	188.1	778.8	103.1	232.8	265.0	103.0	228.5	140.9	188.7	143.4	440.9	144.9
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 742.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	35.2	39.8	86.7	27.0	67.4	35.6	26.1	39.3	81.5	25.4	37.7	23.8	23.1	38.8	24.7	42.3	36.8	28.8	28.2	110.0	70.6	62.8	50.4	50.6	19.8	28.1	63.9	54.1	27.7	36.3	31.5	31.4	19.9	49.9	26.6	36.2	25.7	39.7	34.5	88.5	24.3	33.8	41.5	38.9	22.1	31.5	12.0	41.4	18.3	28.3	49.2	27.8	25.2	21.5	76.6	88.6	62.2	74.4	60.5	105.9	129.7	42.2	71.3	38.5	68.3	29.2	28.4	42.6	28.9	62.8	44.4	48.1	96.6	49.3	44.8	26.1	32.3	32.8	50.7	28.8	46.9	35.4	29.4	73.6	31.5	60.5	78.2	39.6	64.3	54.3	34.9	42.4	44.3	59.8	32.2	48.5	59.6	32.7	28.5	38.2	51.3	62.0	81.0	25.8	54.4	66.6	43.3	42.1	59.1	52.0	48.4	26.7	37.4	21.3	40.5	41.9	27.6	60.3	57.6	32.5	25.4	28.8	27.1	50.5	51.7	46.9	55.6	50.5	68.2	28.3	35.1	74.4	62.2	59.0	72.9	69.5	76.6	73.6	67.8	80.4	64.1	79.8	76.7	17.1	60.5	61.4	88.6	105.9	129.7	86.7	67.4	39.3	81.5	70.6	62.8	63.9	54.1	49.9	41.4	71.5	126.9	126.6	146.5	0.0	174.3	341.7	234.4	156.6	88.7	188.5	55.0	285.1	742.8	226.5	20.4	131.5	123.8	116.8	230.9	258.4	136.0	175.3	101.1	286.9	348.6	144.6	101.8	146.7	171.1	43.8	202.0	160.0	0.0	261.5	229.2	129.5	225.4	259.6	204.4	592.8	122.1	168.1	220.6	53.7	79.5	0.0	257.3	174.0	305.7	185.2
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539103-124568510	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 254.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	26.9	20.8	61.0	19.6	45.1	43.7	33.3	26.9	63.7	20.7	40.4	15.0	25.4	35.5	17.4	30.0	27.9	19.4	23.8	125.1	44.2	39.0	50.1	52.9	23.8	38.2	60.0	49.1	16.8	51.7	20.6	16.3	15.8	46.7	20.6	37.5	13.4	39.9	24.0	221.3	18.0	26.1	31.3	44.8	15.3	28.9	44.1	31.1	13.5	27.7	80.7	19.3	16.7	16.5	53.8	52.7	52.1	54.4	37.5	71.2	64.2	28.8	26.7	20.5	27.7	21.3	18.2	17.2	14.2	16.2	25.9	19.6	35.1	27.9	28.6	36.9	16.3	13.5	32.9	29.7	22.6	24.5	33.2	40.5	69.5	19.0	42.0	28.4	21.6	19.0	21.2	32.9	23.7	51.3	14.1	23.5	20.8	42.9	24.1	20.7	90.1	34.0	43.3	20.6	104.1	59.4	23.0	15.6	39.0	34.0	24.4	28.6	22.4	30.9	254.6	30.4	12.9	35.0	29.3	18.7	15.1	39.4	14.1	33.4	31.1	41.4	32.8	26.3	43.3	19.9	52.1	54.4	27.5	48.3	37.2	47.9	53.8	64.0	53.9	52.7	42.5	63.4	52.2	11.2	37.5	27.2	39.6	71.2	64.2	61.0	45.1	26.9	63.7	44.2	39.0	60.0	49.1	46.7	31.1	116.1	101.5	163.0	206.1	193.5	71.0	877.9	259.9	172.6	153.6	272.2	92.3	413.9	678.1	287.5	321.0	148.3	490.6	46.7	353.1	228.0	195.3	239.3	136.2	450.4	353.4	35.0	224.5	179.2	208.1	585.5	147.0	181.9	234.5	201.0	282.2	86.2	298.7	372.2	143.5	593.2	52.3	168.1	258.4	306.2	277.3	164.6	437.4	148.2	397.6	262.6
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Cell type enhanced"	"Detected in all"	8	"Cardiomyocytes: 1810.7;Distal tubular cells: 963.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.7	3.7	10.7	13.3	7.7	8.4	8.6	10.8	7.2	8.0	6.1	6.5	11.0	3.8	3.9	7.6	7.9	5.2	20.9	7.1	6.3	5.5	6.7	6.1	7.1	10.4	9.7	5.0	3.3	12.1	10.7	7.6	11.2	10.3	7.9	8.8	14.0	16.4	5.5	6.2	7.4	12.4	8.2	16.4	5.0	6.3	6.6	29.1	12.8	5.7	9.1	6.9	7.7	9.5	4.9	9.0	10.4	9.9	3.9	7.9	3.7	5.5	6.1	13.2	23.2	9.6	8.5	13.3	6.3	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5	83.4	126.2	85.5	146.6	124.6	118.7	1810.7	239.5	211.5	137.6	417.0	31.4	127.4	963.3	232.9	260.2	150.4	371.3	93.5	293.9	141.6	109.0	170.1	69.5	334.5	190.8	112.8	212.7	108.1	87.2	30.8	156.8	98.4	253.1	220.0	288.1	223.0	228.9	313.4	194.1	826.9	103.1	97.0	148.0	386.4	224.2	156.7	98.7	62.3	275.8	158.3
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068304-78080219	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	55.0	70.8	40.8	23.3	44.4	32.3	46.2	51.4	58.4	22.5	41.1	31.2	68.0	63.4	31.8	32.8	41.8	35.6	31.9	60.4	41.0	44.5	37.5	89.6	30.1	36.4	43.2	47.0	27.3	48.4	25.3	34.7	31.8	40.8	27.3	20.3	29.7	79.5	59.0	122.8	29.0	55.3	23.7	41.1	24.5	36.6	28.6	23.2	26.9	63.5	43.7	23.3	31.9	24.1	50.3	78.2	70.3	73.2	44.5	46.3	81.2	36.0	45.0	24.5	15.4	23.3	14.7	30.2	44.1	26.5	35.1	25.0	120.6	40.5	21.6	80.9	20.8	28.7	38.1	18.4	25.9	13.4	40.9	52.1	23.2	46.7	94.9	39.8	50.7	23.1	20.4	24.1	26.9	10.2	21.6	23.8	23.2	45.7	36.5	19.6	62.1	33.1	91.4	27.6	88.8	56.9	29.0	46.6	73.1	26.5	54.3	34.6	30.7	31.4	64.8	22.7	22.3	51.3	42.1	31.1	34.2	42.2	81.4	37.8	33.6	65.8	49.7	19.5	30.5	32.7	65.8	73.2	70.3	39.4	58.2	36.2	50.3	45.6	41.5	77.2	45.5	39.6	41.3	21.0	44.5	48.0	78.2	46.3	81.2	40.8	44.4	51.4	58.4	41.0	44.5	43.2	47.0	40.8	23.2	154.9	160.2	100.4	139.2	84.8	134.1	213.8	247.1	202.1	144.5	371.6	62.8	347.5	258.6	334.7	231.4	158.7	177.9	70.0	374.9	317.5	154.4	190.2	148.0	738.1	305.1	85.8	161.2	184.1	179.8	53.3	199.6	133.3	232.8	193.8	274.2	214.0	379.3	301.9	189.5	354.7	91.8	232.8	163.6	380.6	170.3	100.0	323.7	113.3	343.3	186.0
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 534.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	12.9	18.8	13.6	17.6	14.3	21.9	19.1	20.6	31.9	23.2	33.5	15.2	14.7	16.9	23.8	31.7	18.2	25.1	18.5	28.4	6.7	11.8	29.3	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	14.3	24.8	18.6	31.7	14.9	20.7	16.2	17.4	14.0	17.4	21.9	23.1	17.6	26.3	25.4	26.4	23.7	18.4	14.4	22.0	21.6	31.2	26.9	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.6	17.5	17.9	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1	56.6	24.1	13.7	19.6	14.3	94.7	534.9	63.7	60.2	35.2	36.6	113.9	40.2	79.6	36.7	9.9	33.7	63.8	0.0	24.5	26.7	24.7	17.4	35.9	83.9	29.8	111.2	49.0	33.7	34.6	5.2	31.1	25.2	28.7	27.1	47.3	60.7	29.2	35.1	42.1	80.9	78.2	32.3	27.8	28.6	37.3	14.4	43.8	18.7	52.8	23.9
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		NA	NA		16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	17.2	27.8	17.6	20.4	25.9	23.0	15.2	15.7	23.1	31.1	24.5	30.5	18.0	22.0	29.6	24.2	17.1	23.2	28.1	28.1	27.5	14.6	23.6	21.4	20.9	26.6	26.9	23.2	19.9	33.1	24.8	25.1	28.7	20.6	35.5	23.0	27.4	12.0	29.2	19.9	14.7	12.4	32.1	60.6	25.7	12.7	18.2	30.9	36.9	20.7	18.7	27.8	19.0	46.9	26.8	26.3	42.1	60.8	22.7	15.1	12.9	10.6	21.2	16.9	26.7	18.4	23.1	19.6	19.4	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3	32.8	43.7	52.8	39.4	34.6	72.7	193.6	76.5	68.3	35.2	73.3	29.5	125.8	281.8	158.0	7.1	61.2	199.4	23.3	126.2	94.3	73.7	24.9	68.1	177.0	131.6	87.4	69.2	58.9	83.7	4.7	40.3	64.2	79.2	127.2	94.1	51.2	124.2	89.2	31.5	226.7	49.8	45.3	68.0	36.7	32.1	37.9	132.5	50.1	138.8	41.7
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	22.0	18.6	19.4	16.1	16.7	15.9	11.0	18.8	27.2	25.9	32.3	20.4	25.8	11.0	15.7	19.3	21.4	26.3	19.8	22.2	13.8	42.5	15.6	30.9	31.2	16.6	38.1	20.3	16.3	14.3	10.3	17.0	11.6	17.1	21.3	22.7	17.8	17.6	35.4	26.1	49.4	26.4	32.0	31.2	31.8	26.9	21.2	23.3	18.1	20.9	15.1	14.1	24.2	24.9	11.6	27.0	36.4	11.9	16.3	18.3	18.9	24.8	20.5	27.1	28.5	16.5	29.3	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4	50.6	35.2	47.4	60.2	58.3	41.3	154.2	96.8	75.0	45.5	66.3	39.3	103.3	343.2	99.0	93.6	59.9	204.6	23.3	97.2	97.6	64.9	43.1	56.6	108.3	166.7	57.2	81.3	52.8	54.3	46.0	62.5	73.9	113.1	83.8	120.8	100.0	80.5	103.7	65.0	231.7	51.0	103.5	79.3	76.9	75.2	66.4	74.5	62.9	167.5	58.5
NDUFS4	"AQDQ, CI-18"	ENSG00000164258	"NADH:ubiquinone oxidoreductase subunit S4"	O43181	5	53560633-53683340	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003884	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003884: AB_1079465"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.44e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.73e-3)"	"unprognostic (6.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.11e-1)"	"prognostic favorable (3.85e-6)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	27.5	26.5	29.8	15.7	35.7	14.3	34.0	23.3	35.3	20.8	30.0	12.9	21.3	27.6	24.0	24.2	27.0	22.9	20.9	65.1	24.4	23.2	45.3	48.1	18.7	14.9	28.5	34.4	35.7	19.5	22.2	24.9	20.7	26.7	22.9	30.5	16.4	24.4	26.3	105.5	23.0	25.5	34.3	27.0	13.6	24.1	20.9	24.6	12.9	25.1	67.3	19.3	21.7	22.4	24.3	41.0	6.7	32.8	24.5	25.2	21.9	30.0	26.7	53.2	31.4	36.3	52.8	44.7	36.6	35.7	40.7	49.9	32.5	39.6	21.4	48.2	31.2	39.1	22.2	18.8	43.6	47.1	19.7	35.9	14.7	26.5	29.2	38.7	35.3	25.5	43.7	50.5	28.0	49.5	45.0	35.3	24.3	12.5	23.4	37.1	28.1	26.6	29.7	16.1	11.5	30.2	32.1	30.0	42.1	43.3	29.0	24.5	26.6	25.1	24.4	43.0	29.7	39.1	37.2	27.0	25.0	26.7	18.1	47.7	18.0	22.4	25.8	26.7	51.9	36.0	6.7	28.9	2.4	17.5	32.8	19.5	24.3	22.2	20.2	41.0	16.5	25.1	25.2	2.4	24.5	32.4	31.0	23.5	21.9	29.8	35.7	23.3	35.3	24.4	23.2	28.5	34.4	26.7	24.6	35.7	44.6	76.7	128.0	111.7	41.6	329.5	76.5	76.3	71.7	80.3	39.3	136.6	469.2	144.1	42.2	91.5	124.0	0.0	145.6	142.3	128.2	89.3	73.9	126.2	125.7	28.6	86.8	73.6	66.4	51.2	145.9	104.9	111.3	170.5	117.4	77.9	141.9	140.3	143.5	309.1	67.6	122.9	122.6	70.4	45.1	88.7	150.5	58.9	149.5	126.8
NDUFS5	CI-15k	ENSG00000168653	"NADH:ubiquinone oxidoreductase subunit S5"	O43920	1	39026318-39034636	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 1936.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042582	Supported					NA	NA					"HPA042582: AB_2678062"	"unprognostic (1.49e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.97e-3)"	"unprognostic (8.96e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.08e-2)"	56.0	62.1	98.7	34.3	84.4	44.5	55.4	48.6	83.7	36.6	62.0	33.7	49.0	42.8	49.4	114.5	59.2	40.9	40.3	166.0	76.3	69.5	61.5	71.3	30.3	35.4	71.6	65.5	49.1	45.8	36.8	46.3	33.0	49.3	44.8	66.9	35.7	72.6	62.9	150.9	36.9	38.2	64.4	46.9	25.1	44.6	22.4	31.9	30.2	47.2	85.8	43.9	55.3	35.1	38.7	64.7	28.4	53.2	36.4	74.4	59.0	42.8	74.8	56.6	68.3	62.4	66.5	74.8	51.2	42.0	50.7	51.6	89.6	57.9	48.1	70.5	54.7	25.2	30.0	72.3	70.0	56.4	52.8	85.1	47.4	134.8	148.5	43.4	95.6	36.5	66.3	80.3	53.6	48.1	50.5	86.1	50.5	75.7	43.9	24.2	95.5	45.4	123.6	98.3	64.9	77.5	61.5	81.1	76.5	99.9	139.1	79.2	73.1	60.0	75.9	66.1	128.0	51.0	77.5	53.2	41.0	48.5	42.0	86.0	35.4	69.2	68.2	45.1	106.9	55.1	26.1	50.8	28.4	46.1	53.2	52.9	38.7	71.9	53.5	51.7	30.0	74.4	63.5	9.7	36.4	48.9	64.7	66.1	59.0	98.7	84.4	48.6	83.7	76.3	69.5	71.6	65.5	49.3	31.9	154.9	172.8	250.2	316.5	409.4	120.7	1936.4	387.3	269.0	202.4	523.4	35.3	556.6	1158.9	487.9	110.4	342.3	536.4	46.7	470.4	522.0	402.8	334.4	205.5	539.4	482.2	93.8	391.7	255.9	289.3	92.4	326.0	334.5	433.6	373.3	534.7	142.1	537.4	534.4	397.4	1154.8	128.4	278.1	523.5	118.9	99.2	402.4	439.3	231.2	642.6	409.2
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801400-1816605	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 104.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported					NA	NA		27000			"HPA064221: AB_2685217"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	25.0	20.6	19.8	18.9	20.9	23.7	23.9	13.3	26.8	10.6	26.2	11.5	13.6	34.2	13.6	14.4	20.3	10.9	18.8	59.8	17.6	16.5	28.1	43.1	13.5	26.2	19.9	12.9	13.0	29.7	10.5	13.6	17.1	16.1	15.4	12.6	14.7	22.3	19.0	146.4	13.0	27.1	17.8	16.5	16.4	25.4	13.3	9.3	25.5	14.7	36.6	14.1	15.5	12.7	38.7	55.7	35.8	52.8	32.4	40.2	36.7	20.7	28.6	14.0	21.2	5.1	4.6	38.4	17.7	6.3	9.6	8.3	31.5	20.3	28.7	49.1	7.3	18.3	20.7	10.5	14.1	5.2	32.4	34.6	22.1	104.2	26.5	10.3	26.0	19.6	6.5	9.1	9.1	6.5	5.7	9.3	17.2	27.1	22.0	10.3	34.6	37.2	47.6	18.5	23.0	40.3	27.7	18.2	33.6	9.8	23.2	17.3	17.4	57.5	36.9	22.2	8.0	24.6	30.9	18.7	15.2	35.3	15.6	28.7	26.6	40.8	36.7	19.2	37.9	17.2	31.4	46.5	35.8	35.1	52.8	34.9	38.7	37.2	35.5	55.7	31.0	31.5	35.2	20.2	32.4	45.7	54.5	40.2	36.7	19.8	20.9	13.3	26.8	17.6	16.5	19.9	12.9	16.1	9.3	62.5	105.5	111.7	113.4	111.5	87.6	652.0	214.0	129.8	83.0	197.1	45.2	314.0	824.0	224.3	170.3	151.7	605.8	93.5	294.9	176.7	145.1	148.1	103.7	453.3	357.1	62.0	256.5	163.9	217.4	213.8	143.2	152.8	207.5	168.7	287.4	119.2	250.9	375.2	147.8	647.4	112.5	161.7	147.6	204.0	175.7	146.4	205.0	122.2	358.9	170.2
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 688.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.36e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.3	18.7	0.6	4.3	0.6	1.7	9.6	11.1	1.1	2.4	2.6	30.5	4.5	27.2	11.4	0.6	0.3	9.6	0.8	2.2	0.1	30.3	21.4	8.6	19.9	18.9	2.9	14.8	9.5	1.4	3.8	0.4	0.0	0.4	3.2	10.0	17.0	10.7	0.6	19.2	14.7	6.1	6.7	1.6	23.1	14.3	7.1	27.6	1.1	14.2	10.5	10.6	9.8	9.3	18.0	0.0	7.3	9.3	13.9	4.5	6.2	9.7	14.3	42.9	37.5	18.4	11.2	20.0	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6	74.5	95.4	131.8	86.9	79.8	72.1	67.4	168.2	78.9	51.2	137.9	47.1	192.7	688.1	137.5	357.3	76.0	544.6	46.7	141.5	160.0	98.8	68.4	110.7	228.2	287.0	49.3	168.3	69.3	190.4	312.5	77.6	125.3	248.0	122.6	224.8	92.8	114.3	256.1	69.6	490.7	62.6	71.1	129.1	207.7	148.4	92.6	156.2	96.4	322.1	105.1
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 706.2;Proximal tubular cells: 686.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018524, HPA067429"	Enhanced		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA018524: AB_1854355, HPA067429: "	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.4	65.7	18.2	24.7	13.6	12.2	23.9	18.8	16.3	29.1	22.7	61.1	28.3	20.5	34.3	16.3	26.2	32.7	20.8	22.8	10.5	24.5	48.0	18.6	41.9	32.1	32.5	17.4	20.5	15.4	23.7	21.4	24.5	16.1	19.5	28.9	19.1	22.2	19.0	62.7	38.3	37.3	22.3	70.4	55.7	26.7	17.7	66.2	36.6	21.5	22.9	18.6	13.7	31.7	66.4	13.6	43.5	19.1	15.1	28.3	24.9	40.9	25.9	30.5	32.0	17.4	45.5	21.0	19.7	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7	83.4	69.0	76.7	81.4	75.9	80.5	251.3	155.4	84.3	69.4	202.4	51.1	253.0	706.2	176.2	170.4	79.8	264.8	0.0	174.1	132.3	109.2	89.4	94.6	216.5	241.0	47.7	197.0	64.4	119.9	632.4	93.2	101.9	155.3	202.8	173.3	94.1	168.6	178.9	101.5	686.8	98.3	58.2	128.2	84.2	59.4	101.6	144.2	120.4	242.9	99.3
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	25.9	27.9	14.2	28.5	17.8	17.9	26.6	16.2	15.6	25.4	17.0	52.8	31.5	48.0	34.2	13.9	20.7	35.0	30.0	25.3	8.0	24.4	23.7	19.6	37.9	26.0	25.2	26.7	22.0	26.5	24.6	20.6	18.5	16.1	22.5	35.2	35.7	39.3	15.4	39.0	31.2	52.9	13.9	59.1	35.2	36.3	27.6	77.9	20.6	19.5	22.7	21.4	20.5	71.8	54.1	9.9	36.4	27.2	17.8	24.7	18.4	35.1	17.0	38.4	21.8	23.9	28.7	28.3	23.7	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3	56.6	80.9	64.0	70.8	71.3	67.0	408.9	66.2	72.3	67.1	82.0	47.1	180.6	336.5	96.7	57.0	53.7	205.0	23.3	97.8	127.6	79.5	47.7	59.0	122.2	121.6	60.4	94.7	53.4	67.1	159.3	60.7	67.5	108.0	83.8	141.7	63.1	68.4	126.7	55.5	398.9	60.4	45.3	98.9	77.2	78.1	70.4	158.1	71.2	225.4	78.9
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003404, HPA077896"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	20.0	34.5	25.2	18.0	23.7	31.1	25.6	20.6	37.3	15.6	26.1	13.1	20.3	23.1	14.7	21.5	27.5	13.9	17.6	82.6	22.7	23.8	40.7	89.1	17.2	29.9	26.7	19.4	11.2	36.3	14.9	14.9	21.6	26.2	20.8	27.8	17.8	20.1	20.2	122.6	17.4	24.4	23.5	20.8	19.3	25.2	19.0	12.7	20.5	20.5	59.5	22.7	20.4	14.1	55.6	74.7	49.3	45.1	27.0	53.5	48.1	18.6	19.6	22.7	21.1	16.8	24.0	19.2	23.5	37.4	31.1	29.6	36.6	15.4	28.8	21.6	22.0	28.7	9.5	22.0	24.4	29.8	14.5	19.4	18.4	20.2	49.3	19.4	51.2	22.9	20.1	20.5	19.2	20.8	22.5	33.5	26.0	29.3	91.0	28.5	23.4	35.7	44.9	18.9	103.3	24.4	17.0	16.8	109.2	49.6	30.3	23.8	17.7	23.2	26.5	29.5	16.9	24.8	39.0	20.5	39.7	28.2	28.4	30.5	26.3	39.0	32.2	28.3	22.7	25.6	49.3	39.9	44.1	30.2	45.1	37.6	55.6	45.5	35.7	56.6	43.6	40.0	36.9	18.0	27.0	41.6	74.7	53.5	48.1	25.2	23.7	20.6	37.3	22.7	23.8	26.7	19.4	26.2	12.7	74.5	120.4	122.8	254.8	131.4	96.8	61.3	175.8	207.5	127.4	143.1	82.5	309.8	742.8	337.2	214.8	108.5	232.3	46.7	461.4	265.4	107.6	372.3	115.7	324.6	267.7	89.0	102.4	92.7	98.1	135.7	113.1	187.8	219.4	393.1	177.0	104.6	465.3	175.4	95.8	576.3	143.4	103.5	138.2	182.6	170.4	129.0	242.0	118.9	207.0	348.6
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 701.2;Late spermatids: 1042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.4	11.0	18.0	13.6	11.9	13.6	19.2	11.0	11.5	9.6	20.7	11.9	10.7	15.2	7.2	15.6	10.5	12.8	16.9	7.5	6.1	15.5	35.3	13.3	16.2	21.4	12.0	18.5	13.3	14.7	11.6	18.4	10.4	14.4	7.4	27.9	14.0	13.1	18.9	8.0	18.2	14.4	21.5	22.4	13.9	8.0	33.4	15.4	12.8	8.1	8.4	19.3	22.8	12.7	6.2	19.6	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.2	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3	50.6	37.7	43.0	46.0	17.6	69.1	701.2	89.2	92.3	27.3	85.5	64.8	46.1	195.6	69.0	416.9	34.9	128.4	140.2	87.3	49.8	41.1	75.6	30.1	285.4	97.8	54.0	75.1	62.0	81.5	1042.9	61.5	68.7	35.4	67.7	73.4	56.3	83.6	77.2	58.7	265.4	102.6	71.1	47.2	216.7	86.2	20.6	75.2	34.6	82.9	49.3
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Pyrophosphatase (inorganic) 1"	Q15181	10	70202830-70233911	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 942.2;Muller glia cells: 982.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		110000	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	46.6	55.5	41.3	36.8	56.0	24.2	88.7	66.8	62.2	34.8	45.7	25.2	43.7	33.2	30.4	59.6	48.6	38.1	31.5	30.0	46.7	54.2	40.7	59.0	39.1	54.6	74.3	47.5	17.9	72.6	23.3	29.5	34.6	60.7	24.4	53.4	26.1	36.8	42.1	37.0	24.6	41.0	32.8	72.7	22.4	32.5	25.1	47.2	20.4	52.0	35.8	44.4	32.7	40.2	21.5	48.9	1.0	17.7	15.5	35.6	25.3	58.1	24.1	21.6	63.7	58.8	51.9	20.3	21.8	41.1	34.2	36.1	73.5	30.9	84.3	19.9	21.7	22.3	47.1	63.2	42.5	35.0	79.2	60.1	23.0	24.4	41.9	37.2	56.7	14.6	34.0	50.9	27.4	73.1	37.6	41.4	42.8	53.7	45.5	32.2	34.1	54.8	53.2	22.5	80.7	67.0	33.6	24.8	49.3	71.4	36.6	65.0	21.9	24.0	94.1	18.6	15.8	23.5	25.5	18.7	9.5	36.2	31.2	41.3	15.0	32.8	61.8	14.7	79.6	8.3	0.0	17.7	0.4	13.3	13.8	35.6	21.5	30.8	23.1	48.9	13.8	34.2	28.9	1.0	15.5	14.5	11.3	30.1	25.3	41.3	56.0	66.8	62.2	46.7	54.2	74.3	47.5	60.7	47.2	208.4	123.3	139.4	261.1	238.0	182.7	75.4	170.7	77.6	178.6	102.9	163.0	265.6	170.8	481.5	21.2	172.8	203.5	23.3	678.8	222.3	156.3	255.5	36.8	132.9	92.5	81.0	156.1	38.1	69.1	22.2	101.5	81.2	172.1	942.2	201.5	982.7	518.3	210.2	110.3	442.0	227.9	64.7	156.5	149.9	174.8	224.7	205.5	113.0	280.4	496.2
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		8300	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.4	5.4	10.6	18.0	6.8	5.4	7.7	6.5	8.5	8.0	5.7	12.1	16.8	9.4	8.6	5.2	6.4	5.7	21.2	10.3	9.4	13.3	7.6	8.4	8.8	11.0	5.3	19.9	8.2	5.2	10.6	5.5	4.3	9.1	7.6	16.5	14.0	13.0	7.2	14.5	17.0	14.4	7.7	22.3	18.5	15.1	6.5	9.3	26.3	8.8	11.0	6.5	4.4	26.6	9.4	6.5	13.9	16.3	4.0	5.7	11.2	6.2	11.2	11.5	14.5	9.8	10.1	10.8	7.7	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7	8.9	50.5	30.0	71.8	44.4	30.3	55.7	53.5	57.6	43.3	31.4	15.7	106.7	223.8	100.3	91.0	35.1	73.1	23.3	104.8	78.8	31.9	70.3	43.9	59.7	73.9	20.6	63.1	23.4	36.7	95.8	25.6	65.5	72.6	46.9	86.9	28.4	66.2	97.6	30.4	222.1	16.9	38.8	49.5	16.1	9.4	50.4	70.8	45.8	109.9	75.5
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	7	"Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.9	4.2	7.5	7.2	9.4	2.6	4.2	1.9	4.1	7.0	6.1	5.1	4.7	8.1	8.2	2.5	2.0	5.7	7.3	4.9	5.6	8.7	8.3	9.5	4.4	7.4	5.1	6.2	4.8	3.2	9.3	3.7	3.6	5.8	3.3	10.7	7.4	6.8	3.3	9.4	9.5	5.1	7.0	14.3	5.5	8.7	4.8	7.7	5.0	5.4	10.9	8.9	6.3	8.8	5.8	11.1	12.1	9.4	2.3	2.5	3.0	2.7	2.9	16.6	14.0	62.0	2.4	4.7	6.2	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6	6.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	10.4	0.0	3.6	0.0	4.9	0.0	0.0	0.0	0.0	4.9	3.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.8	0.0	0.0	5.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314257-161375340	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 658.2;Proximal tubular cells: 706.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	36.8	49.7	25.6	17.1	27.3	14.1	24.1	14.4	36.2	20.6	29.1	31.2	17.0	34.3	22.1	19.7	35.2	21.4	19.3	35.5	21.5	21.8	65.9	75.3	17.8	20.9	28.6	20.1	20.1	17.2	28.8	17.0	19.2	28.0	20.8	28.4	23.9	28.5	21.9	98.0	21.6	33.4	23.2	24.9	21.2	24.3	17.0	16.2	25.7	35.9	45.4	22.4	20.6	19.2	31.3	60.4	28.3	48.2	29.0	38.6	47.9	29.6	21.7	30.6	26.4	40.4	32.3	33.8	32.9	26.2	25.5	19.8	32.1	36.9	8.8	42.8	33.2	22.9	34.7	40.8	34.6	29.7	31.5	40.0	20.4	20.8	32.9	23.0	37.7	21.9	34.1	28.5	29.7	20.0	31.6	26.6	31.4	28.7	8.3	41.1	28.6	26.8	21.8	30.1	66.8	23.0	28.1	29.9	37.4	53.8	29.5	21.4	36.4	39.6	74.6	47.0	38.0	60.9	47.3	23.4	17.8	27.2	25.1	28.4	43.4	53.0	52.2	26.0	24.7	34.4	27.7	48.2	28.3	36.0	44.9	38.6	31.3	32.3	35.5	60.4	30.6	36.3	35.7	23.9	29.0	38.8	44.8	35.2	47.9	25.6	27.3	14.4	36.2	21.5	21.8	28.6	20.1	28.0	16.2	41.7	50.7	84.8	120.9	55.0	71.4	87.7	163.1	97.7	59.1	143.1	60.9	207.5	658.2	185.1	14.4	65.2	106.6	23.3	127.6	211.0	62.7	94.7	56.6	206.9	208.7	68.3	64.2	75.5	101.7	25.9	95.3	83.6	123.2	205.6	95.6	90.0	123.2	105.2	102.6	706.4	61.9	51.8	92.0	89.9	105.2	66.9	257.2	81.0	139.7	129.5
UQCR10	"HSPC051, QCR9, UCCR7.2, UCRC"	ENSG00000184076	"Ubiquinol-cytochrome c reductase, complex III subunit X"	Q9UDW1	22	29767369-29770413	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 144.4;skeletal muscle: 144.7"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 4128.5;Distal tubular cells: 1946.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.05e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-3)"	23.0	37.0	42.5	18.2	42.9	20.1	23.8	25.2	48.5	17.2	35.5	14.7	24.3	35.9	12.6	24.9	23.7	23.7	19.9	97.9	38.3	30.2	38.3	43.6	22.6	25.2	39.8	25.8	16.1	39.4	19.3	22.5	17.5	25.4	22.2	29.1	21.6	25.2	25.6	144.7	14.7	33.1	17.6	24.2	19.8	29.9	28.5	20.6	20.9	23.6	62.9	20.8	22.8	15.0	132.9	126.0	141.5	118.4	73.9	123.2	144.4	30.9	32.5	31.4	24.4	29.5	19.5	17.5	17.2	21.6	30.9	32.4	41.9	17.9	23.4	18.8	27.3	22.7	31.0	37.2	40.4	19.3	29.2	78.3	29.2	39.5	91.6	21.2	37.5	32.0	32.5	24.8	32.2	21.8	26.0	22.9	25.3	19.9	31.7	30.3	78.1	28.1	44.1	18.0	74.7	43.1	30.7	25.2	42.4	53.2	59.2	34.7	17.5	20.1	43.1	27.1	20.8	30.6	36.0	18.0	32.0	38.7	19.6	25.4	23.9	24.1	31.1	28.8	29.1	20.1	112.9	118.4	141.5	71.0	115.5	77.6	132.9	98.0	90.9	123.1	107.0	106.8	91.6	82.2	73.9	102.8	126.0	123.2	144.4	42.5	42.9	25.2	48.5	38.3	30.2	39.8	25.8	25.4	20.6	229.3	250.2	242.5	180.2	161.5	158.1	4128.5	537.6	353.3	215.0	594.9	72.6	608.3	1946.4	397.6	222.6	157.6	904.3	373.8	481.7	445.1	188.1	297.9	145.6	1099.7	633.2	108.1	365.2	164.5	360.2	448.1	217.1	268.7	295.3	421.2	634.0	208.4	426.1	624.3	194.1	1057.8	204.8	207.0	152.7	328.9	185.1	246.2	486.6	198.4	623.5	323.4
UQCR11	"QCR10, UQCR"	ENSG00000127540	"Ubiquinol-cytochrome c reductase, complex III subunit XI"	O14957	19	1597172-1605490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.4;skeletal muscle: 149.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.90e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.42e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.06e-2)"	24.9	23.6	35.1	15.8	29.5	20.3	18.5	13.2	25.1	12.5	28.5	13.1	20.3	34.4	12.4	18.2	22.9	14.1	21.7	106.4	26.9	21.1	24.4	46.1	11.9	17.2	31.0	19.2	9.8	30.0	8.8	16.7	15.4	18.5	18.3	13.3	14.5	29.6	23.6	149.2	11.5	27.5	16.8	21.5	18.3	27.6	8.8	15.1	10.9	22.0	47.1	12.9	15.8	14.1	63.8	78.6	88.2	75.6	43.8	67.9	125.4	22.5	21.2	10.5	23.8	17.5	12.0	25.5	16.3	12.8	16.0	14.3	34.2	15.2	13.3	16.9	11.5	4.1	14.4	15.4	17.3	7.5	21.8	47.1	11.7	26.2	32.1	18.2	19.3	18.3	18.5	17.9	10.1	11.8	8.3	14.5	19.5	25.8	24.2	10.1	31.0	19.2	23.4	27.4	18.2	51.0	11.6	11.0	44.4	20.9	45.5	20.8	22.3	11.2	27.1	28.7	8.2	19.2	23.1	20.2	15.6	10.1	41.1	18.9	34.2	28.1	16.3	27.4	20.2	21.1	83.7	75.6	87.0	52.6	61.8	52.9	63.8	64.3	58.2	63.1	54.1	61.7	59.3	88.2	43.8	57.4	78.6	67.9	125.4	35.1	29.5	13.2	25.1	26.9	21.1	31.0	19.2	18.5	15.1	250.1	365.3	312.4	147.9	0.0	116.7	1545.7	580.9	491.2	293.5	601.9	37.3	421.8	1518.6	593.8	133.9	281.1	1267.5	350.4	708.1	511.1	324.6	312.1	183.7	1781.4	835.4	84.2	436.5	444.4	741.4	307.4	234.1	456.9	0.0	926.1	940.5	193.7	712.8	958.2	244.0	853.5	119.2	219.9	179.7	157.0	128.1	0.0	428.8	332.1	797.4	248.2
UQCRB	"QCR7, QP-C, UQBP, UQCR6"	ENSG00000156467	"Ubiquinol-cytochrome c reductase binding protein"	P14927	8	96225920-96235634	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 234.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 4932.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043060	Approved					NA	NA		380000			"HPA043060: AB_10806376"	"unprognostic (5.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.66e-3)"	37.8	51.7	52.1	27.8	54.3	31.3	27.9	25.5	44.0	31.1	37.7	17.9	28.5	35.2	30.7	41.3	38.6	25.5	27.9	156.1	42.3	39.6	57.3	45.1	22.0	28.1	52.2	35.6	48.7	35.2	25.5	45.5	20.3	41.9	35.6	33.8	19.4	42.0	31.7	234.1	16.8	31.7	57.8	44.3	26.9	30.6	15.5	30.8	22.9	33.0	90.0	31.9	51.2	33.8	50.3	38.5	31.9	65.4	30.3	64.4	46.4	52.7	25.3	32.8	20.9	47.5	48.6	21.4	42.7	32.6	23.7	25.5	22.9	25.5	23.0	64.9	34.2	24.6	26.0	29.9	39.8	31.8	34.6	23.8	75.7	48.6	37.9	34.9	41.9	32.4	56.7	35.7	26.7	42.6	77.4	34.3	38.8	39.8	40.1	36.3	34.2	66.6	64.2	19.3	109.5	38.9	29.9	21.7	42.5	46.4	42.4	30.2	30.1	25.8	9.9	64.7	45.8	40.8	70.3	41.7	15.6	23.7	27.3	45.5	34.7	26.0	53.3	25.6	56.6	16.9	26.6	34.8	31.9	32.2	56.4	39.5	50.3	52.0	40.2	38.5	38.7	64.4	58.8	24.7	30.3	65.4	33.7	56.8	46.4	52.1	54.3	25.5	44.0	42.3	39.6	52.2	35.6	41.9	30.8	413.9	522.6	695.6	387.7	268.5	266.1	4932.0	861.1	515.3	513.0	315.8	110.0	494.8	2105.5	666.2	870.6	469.6	871.3	210.2	806.3	418.8	464.2	366.1	567.6	867.4	984.6	119.2	702.2	585.0	1469.2	177.7	799.9	759.0	777.7	959.4	915.4	233.9	819.0	855.1	677.5	1659.4	303.1	530.3	608.7	264.6	241.0	254.4	500.5	684.9	974.2	501.5
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		1300000	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.1	16.5	6.0	3.6	8.8	8.1	27.1	18.8	15.2	15.6	14.2	25.6	3.0	26.3	11.9	8.4	18.3	9.8	7.5	21.8	2.9	15.6	35.9	27.0	14.3	27.7	17.5	16.9	11.7	11.1	24.8	10.6	17.5	7.4	15.5	17.4	14.5	1.8	9.4	17.7	12.2	19.3	15.0	15.0	65.5	8.3	16.0	21.5	16.1	11.1	6.4	11.4	25.4	3.1	15.0	1.7	6.5	2.7	15.5	4.3	16.5	13.6	19.3	16.0	14.1	15.2	9.6	19.5	13.9	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4	53.6	50.3	63.6	133.4	104.5	38.0	576.9	142.7	78.9	46.6	115.1	27.5	292.1	310.0	150.4	116.4	44.8	496.0	46.7	145.4	266.4	68.1	72.4	80.8	173.2	214.8	38.1	138.8	44.2	110.4	218.8	54.1	87.6	113.1	113.6	228.6	55.4	138.8	252.6	66.4	309.3	39.8	58.2	92.9	102.7	76.4	92.1	281.6	56.5	307.7	117.4
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1206.2;Distal tubular cells: 877.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	21.8	37.0	13.8	12.4	22.6	17.3	15.3	17.1	17.9	23.7	26.3	22.4	13.6	19.9	18.1	19.3	19.4	23.3	30.1	20.4	28.7	13.5	30.1	28.2	14.6	20.3	19.2	26.8	24.8	20.8	22.1	16.2	24.7	14.0	18.9	24.9	20.0	12.5	25.4	20.2	18.7	20.1	14.4	46.7	14.4	17.1	18.4	15.1	29.5	26.4	16.8	8.2	15.6	30.9	19.6	16.1	14.4	22.4	11.9	16.1	24.5	11.0	17.7	6.0	11.3	18.4	14.2	23.3	11.4	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5	50.6	43.5	83.4	229.0	131.1	67.3	1206.2	170.7	48.2	45.5	108.2	15.7	255.3	877.0	208.2	176.6	94.4	303.4	70.0	204.7	204.0	122.3	162.8	88.9	250.4	234.4	49.3	153.7	93.9	135.6	102.8	85.4	113.1	156.9	178.5	238.4	96.8	186.1	196.4	76.7	532.4	58.7	97.0	163.6	296.9	77.1	140.0	319.3	108.3	325.0	307.9
UQCRH	"QCR6, UQCR8"	ENSG00000173660	"Ubiquinol-cytochrome c reductase hinge protein"	P07919	1	46303631-46316776	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042574	Supported					NA	NA					"HPA042574: AB_10960998"	"unprognostic (2.24e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (4.63e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.04e-1)"	31.3	25.8	57.4	29.5	56.6	52.2	36.7	59.1	73.9	28.4	63.4	11.6	37.1	61.3	23.6	32.8	48.5	18.3	28.9	140.9	48.8	48.6	52.5	38.8	22.2	37.0	55.9	57.0	36.5	66.4	33.4	25.3	21.2	52.9	23.1	64.2	18.9	60.5	40.4	132.5	26.3	44.2	38.4	42.7	24.6	37.3	14.0	26.7	23.9	20.5	76.0	49.4	29.6	30.1	82.4	72.4	35.8	56.4	30.5	57.7	82.4	49.1	28.8	34.4	61.4	35.2	47.9	71.4	32.7	19.5	28.2	24.2	55.6	27.2	48.4	43.5	30.3	52.8	35.4	47.6	50.0	42.0	36.2	82.0	120.2	83.2	74.2	20.7	118.2	34.4	54.1	28.6	46.7	23.5	43.2	39.5	60.5	113.1	54.0	42.8	37.9	53.1	120.6	205.3	61.1	59.0	56.0	56.4	150.6	61.7	105.1	66.8	79.4	53.6	100.9	100.5	95.0	33.5	146.3	35.5	27.5	36.0	39.4	60.7	37.0	73.3	76.2	39.9	92.0	41.1	20.4	56.4	35.8	35.2	47.9	45.1	82.4	50.8	46.2	72.4	61.5	57.7	51.5	10.7	30.5	40.8	49.6	50.5	82.4	57.4	56.6	59.1	73.9	48.8	48.6	55.9	57.0	52.9	26.7	98.3	125.7	583.3	503.9	406.7	272.2	1846.1	557.9	152.6	193.3	373.4	157.1	587.0	1779.0	451.3	50.7	322.9	766.9	210.2	303.5	704.1	295.5	485.5	281.3	508.0	631.3	96.9	482.7	305.1	657.1	51.7	286.0	422.8	464.0	348.9	986.2	177.1	370.2	653.5	267.3	1048.7	322.7	323.4	420.5	100.7	334.1	460.6	543.7	320.4	1157.3	702.1
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3256.1;Hepatocytes: 4283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.5	63.7	37.6	91.0	56.4	45.9	32.6	33.1	46.7	53.0	66.1	89.7	53.3	18.7	70.0	43.3	67.4	46.2	34.3	80.6	45.6	34.2	72.0	24.8	100.5	70.5	49.0	28.1	42.8	48.9	56.2	37.8	52.2	35.5	41.3	40.4	31.7	60.4	55.5	86.2	64.6	64.9	26.7	85.4	57.6	42.4	41.7	80.5	68.5	89.0	63.1	52.5	40.9	46.2	70.6	27.0	68.8	64.9	25.7	48.6	61.4	39.8	66.8	66.8	88.7	33.5	64.6	52.5	48.3	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8	232.3	318.2	275.9	309.6	309.4	83.7	3256.1	1189.8	321.2	221.8	746.8	113.9	633.7	1536.9	621.2	357.1	305.7	1715.1	233.6	826.7	362.7	374.6	615.6	285.5	4283.6	668.1	68.3	527.7	324.1	428.0	786.4	261.5	374.1	678.2	396.8	861.3	232.4	704.3	1273.0	271.5	1804.0	170.0	181.1	456.8	296.8	123.0	449.3	470.6	222.6	1052.4	401.6
